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Abstract
An estimated 35% of the human proteome is intrinsically disordered. Disordered proteins
play a key role in physiologic and pathologic regulation, recognition, and signaling making
protein disorder the subject of increasing investigation. Since disordered samples do not generate
x-ray quality crystals and since they have conformations that interconvert faster than the time
resolution of NMR or ESR, little is known about their structure or function. By combining
isotope-edited two-dimensional infrared spectroscopy (2D IR) with spectral modeling based on
molecular dynamics simulations, this work will show that one can measure the residual structure
and conformational heterogeneity of a putatively disordered sequence.
This methodology was first used to study the structure and dynamics of the tryptophan
zipper 2 (TZ2) peptide. The TZ2 peptide is a 12 residue engineered sequence that employs the
"tryptophan zipper" motif to stabilize a p-hairpin fold. For this work five isotopologues of TZ2
were synthesized, the p-turn label K8, the midstrand labels T10 and T3T1O, the N-terminal label
S1, and the unlabeled peptide UL. Temperature dependent FTIR and 2D IR studies in
conjunction with modeling revealed that the TZ2 peptide at low temperatures exists as a folded
peptide with a type I' turn and a small previously unobserved subpopulation of a bulged loop structure.
Upon heating a fraying of the peptides termini is observed, in addition the population of the type I' turn
increases relative to the population of the bulged turn. The TZ2 peptide provided a model hairpin system
to test the utility of different forms of analysis and isotope labeling patterns for the subsequent study of
disordered hairpin peptides.
This methodology was next employed to gain insight into the structure of the elastin-like
peptide GVGVPGVG, a prototypical disordered system. For this work nine isotopologues were
studied in addition to size dependent variants based on the VPGVG sequence and point mutants
variants of the form GVGXPGVG. The conformational ensemble was found to contain a high
3
population of irregular P-turns possessing two peptide hydrogen bonds to the proline C=O (see
figure below). Further, it was found that this population grows as a function of 1) side-chain
volume for the peptide series GVGXPGVG, where X = Gly, Ala, and Val, and 2) polymer size
for the peptide series GVG(VPGVG)a, where n = 1-6 and 251. These findings provide new
insight into the molecular origin of the mechanical properties of biopolymers containing XPG
turns including collagen (X = Pro), elastin (X = Val), mussel byssus (X = Gly), dragline spider
silk (X = Gly), and wheat glutenin (X = Gln).
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Figure Al. On the left is a 2D IR spectrum of GVGVPGVG at T = 10*C in pH
1.0 DCl in D20. The green box in the spectrum highlights the red shifted amide I'
proline peak feature associated with the presence of an irregular p-turn which is
depicted on the right. The green dotted lines in this structure indicate the location
of the two hydrogen bonds to the proline C=0.
Thesis Supervisor: Andrei Tokmakoff
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The presented work is dedicated to my parents, Judith and Jeffrey Lessing, whose tireless
commitment to my education made this thesis possible.
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"I love it when a plan comes together."
Colonel John "Hannibal" Smith
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Chapter 1
Preface
1.1 Introduction
Protein conformational dynamics lie at the heart of numerous biophysical processes,
including protein folding, substrate binding, molecular recognition, and self-assembly.
Historically, such processes were often conceived in terms of rigid protein molecules with
minimal conformational degrees of freedom. However, structure formation in such processes
involves a complex interplay between the favorable energy of contact formation and
conformational entropy. Protein flexibility and conformational heterogeneity are intrinsic to all
systems, but this disorder and its role in biophysical processes remains difficult to study and
describe experimentally. This stems from a paucity of methods that can explore these questions.
Conformational dynamics occur over picosecond and longer timescales, and atomistic structural
resolution in solution is only routinely available from computer simulations. The most detailed
experimental observations have emerged from magnetic resonance spin relaxation rate
measurements that characterize inherently disordered proteins,' residue-level protein folding, 2
transient protein-protein complexes,3 4 and microsecond structural fluctuations. 5~8  Two-
dimensional infrared spectroscopy (2D IR) is an emerging method that is being used to directly
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measure structure and conformational dynamics in proteins and peptides. 9-14 Analogous to
multidimensional NMR, 2D IR observes structure sensitive vibrational couplings through cross
peaks in a 2D spectrum.1 5  In addition, 2D line shapes provide information on molecular
flexibility and solvent exposure through their peak frequency and ellipticity. Time-dependent
changes to cross peaks and line shapes reveal chemical exchange processes and fluctuations.
Since the measurement time scale for vibrational spectroscopy is in the picosecond range, such
studies provide an avenue to characterize conformational variation and ultrafast fluctuations. The
technique has been used to measure protein structure and dynamics with particular focus on the
amide I vibrations, which are sensitive to secondary structure and the local hydrogen bonding
geometry of the peptide groups. 9-12 16-20
Extensive study of small peptides has revealed the local forces that contribute to protein
secondary structure. 21-30 In contrast, far less is known about the forces that contribute to the
structure of disordered proteins where local effects dominate.31~37 One striking example of a
poorly understood disordered protein is elastin whose structure, despite extensive investigation,
remains unassigned. Elastin is a ubiquitous component of the extracellular matrix of animals and
is responsible for the elasticity of bodily tissues such as the skin, arteries, and lungs. 3 8-41 The
elastin protein has been the subject of interest in biology, chemistry, and material science
because of its strength, durability, phase transition behavior, and ability to self-assemble. 42-45 To
date the molecular origin of these properties is unknown owing to a dearth of structural tools that
can perform measurements on the elastin fiber. Elastin protein cannot be crystallized, and X-ray
diffraction or scattering studies provide limited structural information. Although NMR is
selective to long lived conformational states, since conformational exchange for elastin occurs on
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picosecond to nanosecond time scales, NMR cannot be used to resolve its conformational
heterogeneity.3 s,46
Some clues in to the mechanism of the proteins elasticity have been revealed through
amino acids sequence analysis. The amino acids sequence of elastin consists of cross-linking
domains with a high percentage of lysine with alanine or proline and hydrophobic elastic
domains with a high percentage of alanine, glycine, leucine, isoleucine, proline, and valine. 7 49
In addition these elastic domains are found to consist of small repeating blocks of PGV, PGGV,
PVGG, PGVGV, PGVGVA, and PGFGVGAGV generating a simple biopolymer. One
dominant and extensively studied elastin repeat sequence is PGVGV, as a result the canonical
elastin mimic GVGVPGVG (GVGn1) was used as a model system.
The investigation of elastin presented in this work is broken down into 4 main chapters
which will focus on the synthesis, vibrational spectroscopy, and structure of two amide I' isotope
labeled peptides, Tryptophan Zipper 2 (TZ2) and GVGn1. Chapter 2 will present the steps taken
to synthesize the peptides studied. An explanation of Fmoc solid phase peptide synthesis (SPPS)
will be provided including reaction mechanisms, guidelines for designing a peptide synthesis,
methods for avoiding unwanted side reactions and peptide cleavage. This chapter will also
discuss the synthesis of Fmoc amino acids with 180 amide I' isotope labels for use in SPPS. In
Chapter 3 a 2D IR study of the 12 residue TZ2 is presented. TZ2 is an engineered peptide that
contains four indole rings from the peptides tryptophan side-chains whose interaction stabilizes
the formation of a p-hairpin fold. TZ2 was chosen because it has been the subject of numerous
spectroscopic and theoretical investigations and as a result is an ideal model system for
understanding vibrational couplings in small hairpin peptides. This work will act as a template
for the approach used in Chapter 5 for studying the GVGn1 peptide by demonstrating the ways
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in which isotope labels can be employed to understand peptide structure and dynamics. Next in
Chapter 4 the GVGXPGVG peptide will be introduced where X = Gly, Ala, and Val. This point
mutation was found to significantly alter the turn structure for the peptide with an increase in the
population of closed turns as a function of increasing side-chain volume. Finally in Chapter 5
more subtle aspects of the GVGnl peptides structure were explored using a library of 9
isotopologues as well as oligomers based on the PGVGV sequence. These peptides were studied
as both a function of temperature and salt concentration providing information on the local
structural changes that occur as the peptide transitions from its unfolded to folded state.
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Chapter 2
Synthesis of amide I isotope labeled peptides
2.1 180 Isotope labeling
Amide 1 180 isotope labeling was performed via acid hydrolysis in mixed H2180 and
organic solvent. This synthesis was designed based on the procedure of Murphy et. al.l for the
180 labeling of the carboxyl moiety of an unprotected amino acid. In their simple procedure a
solution of an unlabeled amino acid was dissolved in acidic H2180 and refluxed at 60-70*C for
several days generating over 90% isotope enrichment without racemization. This procedure was
modified for the present work in order to isotope label amino acids with an N-terminal
fluorenylmethyloxycarbonyl (Fmoc) protecting group (Figure 1). The Fmoc moiety was
O N COOH
0: R
Figure 1. N-terminal Fmoc protected amino acid.
necessary because it is needed for solid phase peptide synthesis (SPPS) which will be discussed
later in this chapter. Since the Fmoc group is hydrophobic an organic co-solvent was added to
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aid in dissolving the protected amino acids in H2 180. The desired co-solvent for the labeling
reaction would dissolve Fmoc protected amino acids, would be easy to remove by lyophilization,
and would not act as a source of 160 during labeling. Acetonitrile was originally used for this
purpose but was replaced with 1,4-dioxane 2 due to the undesired hydrolysis of acetonitrile to
generate an isotope labeled acetamide. 3 The first amino acid to be 180 labeled was serine (Ser or
S) for incorporation at the N-terminal Serl position in the Tryptophan Zipper 2 (TZ2) peptide
NH2-SWTWENGKWTWK-CONH 2. The procedure presented below details the synthesis of the
isotope labeled Ser using acetonitrile as the co-solvent, though this procedure can be generalized
to the labeling of other none hydrolysable amino acids using 1,4-dioxane as a co-solvent
including aspartic acid (Asp or D), glutamic acid (Glu or E), threonine (Thr or T), proline (Pro or
P), alanine (Ala or A), valine (Val or V), leucine (Leu or L), isoleucine (Ile or I), phenylalanine
(Phe or F) and tryptophan (Trp or W). Though in the case of Asp and Glu subsequent side-chain
protection is difficult because it requires the selective protection of the carboxylic acid side-chain
while keeping the main chain carboxylic acid deprotected. Labeled Ser was synthesized directly
from Fmoc-Ser-OH (Novabiochem) using acid catalyzed hydrolysis. First the glassware for a
reflux reaction was assembled, which primarily consisted of a two-neck round-bottom flask and
a condenser, and heated under vacuum for 20 min at 110 C for the purpose of removing ambient
H2 160 water. The reflux setup was then cooled under positive N2 pressure to prevent
contamination from ambient moisture. Next 0.131 g of Fmoc-Ser-OH was dissolved in a
minimal amount of acetonitrile (-3.5 ml) and injected into the reaction vessel followed by the
addition of 97% isotope enriched H2 180 (Isoflex USA) in a 1:4 ratio of H2 180 to acetonitrile. It
should be noted that the ratio of water to organic solvent will change dramatically depending on
one's choice of amino acid and co-solvent.
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Next the solution was acidified either by bubbling anhydrous HCl gas through the
solution or generation of HCl in situ through the addition of acetyl chloride. HCl gas was
generated by heating a powdered mixture of anhydrous sodium bisulfate and sodium chloride.
NaHSO 4(s) + NaCI(s) + HCI(g) + Na 2 SO 4 (s)
To do this 0.717 g of NaCl and 1.137 g of NaHSO 4 were finely ground, mixed and placed in a
small septum sealed round bottom flask. The flask was then purged with nitrogen following
which two syringes with stopcocks were inserted into the septum. Next the first stopcock was
opened and the flask was heated with a hand held propane torch until the syringe contained 20-
30 ml of HCl gas. Since the first aliquot of evolved gas is mixed with N2 this gas was disposed
of by bubbling it through a flask containing H2 160 water. Next the second stopcock was opened
and the flask was again heated until an additional 10 ml of gas was collected. This gas was then
bubbled through the dissolved Fmoc-Ser-OH solution until the pH = 1.0. Alternatively HCl can
be generated in situ by injecting a solution of 1M acetyl chloride in dichloromethane (DCM)
(aldrich) into the reaction vessal which hydrolyzes to form HCl and acetic acid.2
The solution was then refluxed at 1000 C for 72hrs and lyophilized generating a -75%
isotopically enriched sample. Alternatively the H218 0/organic solvent mixture can be removed by
distillation thereby providing material for future low isotopic enrichment of amino acids. For the
Ser and ThrlO 180 isotope labeled TZ2 peptides described in chapter 4 the amino acids were
incorporated into the peptide at -75% enrichment though for the GVGnl peptides discussed in
chapters 5 and 6 the labeling procedure was repeated to achieve -97% isotopic enrichment. Next
a sample was extracted from the solution for electrospray mass spectroscopy to determine the
percent isotope incorporation (these mass spectra and HPLC data are presented in the appendix).
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Fmoc Solid Phase Peptide Synthesis
X = Main chain protecting group
Y = Side-chain protecting group
A = Carboxy activating group
Removal of the main-chain
protecting group
R
x
IH2
Coupling 0 H
+ A NX
R
1) Removal of the main-chain
protecting group
2) Cleavage from the resin and
side-chain deprotection
NH 2
0
Figure 2.Steps involved in performing Fmoc SPPS.
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2.2 Solid Phase Peptide Synthesis
SPPS is a process for generating peptides and small proteins by sequential tethering of
amino acids to a linker on a solid support. The main advantage of SPPS is the use of a
heterogeneous synthesis approach thereby simplifying purification between reactions to rinsing
and filtration of the solid support. The development of SPPS by Robert B. Merrifield 4
represented a paradigm shift in biochemistry and pharmacology, by making peptide synthesis
simple, practical, and automatable.
The steps of an SPPS synthesis can be broken down into deprotection, coupling, and
cleavage. During "deprotection" the growing resin bound peptides main-chain protecting group
is removed exposing the C or N-terminus for the benzyloxy-carbonyl (Boc) or Fmoc procedures
(Figure 2) respectively. Next a "coupling" step is performed which adds the subsequent amino
acid in the peptide sequence. These steps of deprotection and coupling are then repeated for
each amino acid addition until the desired sequence is generated. Finally a "cleavage" step is
performed removing side-chain protecting groups and main-chain linkers to generate the peptide
product.
The two common methods for solid phase peptides synthesis are acid labile Boc synthesis
and base labile Fmoc synthesis.5- 8 Although each method requires different resins, side-chain
protecting schemes, reagents, and synthesis directions the underlying principle remains the same.
The significant difference between the Boc and Fmoc procedures is the choice of main-chain and
side-chain protecting scheme. For Boc SPPS the peptide is synthesized from the N to the C-
terminus using a Boc protecting group on the C-terminus which is labile under mildly acidic
conditions typically using trifluoroacetic acid (TFA). In contrast the side-chain protecting
groups and the linker are cleavable under harsh acidic conditions typically using hydrofluoric
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acid. As a result the side-chain and main-chain protecting groups as well as the linker are
cleavable under acidic conditions resulting in a slow loss of side-chain protecting groups and
cleavage during sequential steps of amino acid coupling thereby lowering the final yield of the
peptide. Since peptide synthesis requires multiple steps a small reduction in yield at each step
propagates to generate a larger reduction in the yield of the final product. For example the
longest and shortest peptides studied in this work are GVGVPGVG requiring 7 coupling steps
and GVG(VPGVG) 6 which requires 32 coupling steps. If the yield for each coupling step
decreases from 99% to 97% the final yield for GVGVPGVG would decrease from 93% to 81%
and for GVG(VPGVG)6 would decrease from 72% to 38%. As a result optimizing the yield of
each step in a peptide synthesis is of paramount importance. An easier and safer alternative to
main-chain protection with Boc protecting groups is the use of the orthogonal Fmoc based
protecting scheme. For this approach the peptide is synthesized in the opposite direction from
the Boc procedure, i.e. from the N to the C-terminus, using a main-chain protecting group on the
N-terminus. Here the side-chain protecting groups and main-chain linker are label under mildly
acidic conditions, and the main-chain is protected with the Fmoc group which is labile under
basic conditions. This approach allows for the deprotection of the main-chain functional group
at each sequential step of amino acid addition without deprotecting the side-chain groups or
cleaving the peptide and is therefore termed an orthogonal synthesis. This orthogonal synthesis
approach in conjunction with the use of more mild reagents makes Fmoc SPPS a natural choice
for the synthesis of the peptides studied in this work. Below is a detailed description of the steps
involved in performing an Fmoc synthesis.
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2.2.1 Choosing a resin
SPPS synthesis begins with the selection and preparation of a resin. Many factors a
considered when choosing a resin such as the chemical composition of the polymer support,
degree of cross-linking, degree of swelling upon solvent addition, resin size, resin size
distribution, choice of linker group and binding capacity. 9'10
Typical polymer support materials include polystyrene, polyacrylamide, or a copolymer
of polyethylene glycol (PEG) grafted to polystyrene. When choosing a polymer matrix it is
important to match the hydrophobicity of the polymer with the hydrophobicity of the solvent
system in use and the sequence being synthesized. Matching the hydrophobicity of the polymer
to that of the solvent increases the swelling of the polymer thereby increasing the rate of
molecular diffusion with in the resin. Matching the hydrophobicity of the polymer support and
the solvent to that of the sequence being synthesized improves both coupling yields and yield
upon cleavage. To increase coupling yields, especially for the synthesis of long sequences, it is
important that the peptide exist in an extended conformation while attached to the resin in order
to keep the peptides terminus accessible for the coupling of sequential amino acids. Matching
the hydrophobicity of the sequence to that of the polymer and solvent allows the peptide to
remain in an extended state during synthesis. Finally a common cause of poor yields in SPPS is
destruction of the peptide upon cleavage. One cause for this is resin nucleated aggregation of the
peptide product after cleavage. Using a polymer with a similar degree of hydrophobicity reduces
the probability of polymer mediated aggregation.
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2-Chlorotrityl Resin Wang Resin Rink Amide-MBHA Resin
H3CO NH2
CICI H3CO
Figure 3. Common linkers used for SPPS. Blue circle - solid polymer support; Green
square - peptide attachment point.
The hydrophobic cross-linked polystyrene was used for the synthesis of all peptides
presented in this work. All resins had a 1% divinylbenzene (DVB) cross-linking which is a
common choice for SPPS because it provides the resin with mechanical stability while still
allowing for resin swelling which is required for fast chemical diffusion. All resins had a size
distribution of 100-200 mesh (75-150 pm) where both the resins size and size distribution effects
an SPPS processes yield. The absolute size of a resin particle determines the surface area to
volume ratio of the resin which in turn determines its swelling property's whereas the size
distribution determines the degree of uniformity of reaction conditions in the ensemble and in
turn the degree to which the reaction can be optimized. The linkers used in this study were 4-
(2',4'-Dimethoxyphenyl-Fmoc-aminomethyl)-phenoxyacetamido-norleucyl-MBHA resin (Rink
amide MBHA resin), 4-benzyloxbenzyl alcohol (Wang resin)", and 2-chlorotrityl chloride
12(Barlos resin) , which were purchased from Novabiochem (Figure 3). Rink amide MBHA resin
was used for the synthesis of the TZ2 peptide because upon cleavage it generates the desired C-
terminal amide group -CONH 2. In addition the rink amide MBHA resin does not require a
separate synthetic step for the coupling of the first amino acid to the resins linker13 , termed
preloading. Wang resin was used preloaded with glycine for the synthesis of elastin-like
peptides in order to generate the desired C-terminal carboxylic acid group. Finally 2-chlorotrityl
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chloride resin was used for the synthesis of the ELP polymer precursor Boc-GVGVP for two
reasons 1) the steric bulk of the 2-chlorotrityl linker prevents the creation of a
diketopiperazines12,14,is which commonly occurs for Pro-Wang resin and 2) the 2-chlorotrityl
linker can be cleaved under mild conditions'2 '14 "5 (see section on peptide cleavage) allowing for
the removal of the peptide from the resin while still retaining the desired N-terminal Boc
protecting group.
Since the 2-chlorotrityl resin was purchased without pre-loading an additional step was
necessary to attach the first amino acid Fmoc-Pro-OH to the resin. This was accomplished by
dissolving 1.2 equivalents of Fmoc-Pro-OH relative to the mols of linker, which is expressed as
(mmol of linker)/(grams polymer) which gives the linker substitution, and 4 equivalents of N,N-
Diisopropylethylamine (DIPEA) in dry DCM. This solution was then added to the resin and
stirred for 120 min. Next the resin was washed with 3x DCM/MeOH/DIPEA (17:2:1), 3x DCM,
2x DMF, 2x DCM and dried under vacuum.
After resin selection 0.1 mmol of resin was weighed out for the peptide synthesis where
the scale of the synthesis is limited by the size of the reaction vessel and the degree of swelling
of the resin. For this work Rink amide MBHA resin was used at a linker substitution of 0.69
mmol/g, Fmoc-Gly-Wang resin was used at a linker substitution of 0.78 mmol/g, and 2-
chlorotrityl chloride resin was used with a linker substitution of 1.20 mmol/g. It should be noted
that the substitution levels used in this work are skewed towards higher levels of substitution
where the typical range is from 0.5-0.8mmol/g. A higher degree of resin substitution was chosen
because of the small size of the peptides being synthesized. For the synthesis of difficult
sequences or sequences longer than 25 amino acids a linker substitution of 0.1-0.2mmol/g is
more appropriate.16
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2.2.2 Deprotection
400HN
Hd O N N
H lyH
-H0C2 H2N____
0 0
NH2+- HN
+N N
Figure 4. Mechanism of Fmoc deprotection with piperidine. Purple - carbamate; Blue -
Dibenzofulvene.
The first automated step in the SPPS procedure is the cleavage of the Fmoc protecting
group from the resin in order to unblock amine sites for the addition of the first amino acid. To
accomplish this, the resin is suspended in dry DMF for 40 min to allow the resin to swell before
application of reagents. This step and all subsequent steps up to peptide cleavage were
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performed under dry N2 to avoid reductions in yield due to hydrolysis. Next the resin was
suspended 2x in a 20% piperidine in DMF solution for 7 min. First the piperidine removes the
Fmoc group via base-induced p-elimination followed by evolution of the carbamate linkage as
CO2 gas (Figure 4). Finally the piperidine scavenges the highly reactive dibenzofulvene
byproduct to form a stable adduct5 '6 . The resin was then cleaned by rinsing with 6x with DMF
for 30 sec to remove piperidine and the dibenzofulvene/piperidine adduct leaving behind the
unprotected product.
2.2.3 Activation and Coupling
N ." X-
Fmo FmocN X NR N 0-/
N ~ O +,
Fmoc< N--
FmFmoc O N 
N
N-
/H
N HI
Figure 5. Reaction mechanism for the activation of an amino acid by the reaction of
HBTU with an unprotected carboxylic acid to form a HOBt ester. Blue - Urea; Green -
Triazolol; Purple - O-Acylisourea; Yellow - HOBt ester.
To perform the first coupling step the carboxylic acid of the Fmoc amino acid being
coupled to the peptide is activated using a triazolol based salt as a coupling reagent before being
add to the growing peptide. To accomplish this a solution of 0.4 M N-methylmorpholine in
DMF was added to a vial containing a dry powdered mixture of Fmoc amino acid and coupling
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reagent in a 4x excess relative to the number of linkers on the resin. This solution was mixed for
30 sec before being injected into the reaction vessel to create a suspension of resin and activated
amino acid solution. The mechanism for the formation of the activated Fmoc amino acid using
the coupling reagent O-benzotriazole-N,N,N',N'-tetramethyl-uronium-hexafluorophosphate
(HBTU) is shown in Figure 5. In the first step nucleophilic attack of the Fmoc amino acids
carboxyl group oxygen on the central carbon of HBTU's urea moiety generates the 0-
acylisourea intermediate. The urea moiety is then replaced by hydroxybenzotriazole (HOBt) to
form the more stable HOBt ester which is the activated form of the Fmoc Amino acid. This
activation step dramatically increases the rate of acylation though caution should be used before
using a large excess of coupling agent to prevent overactivation. Overactivation occurs when the
acylating agent is strong enough that it is no longer selective and acylates both the primary amine
on the backbone and weaker nucleophiles such as hydroxyl groups. Next the suspension was
then mixed for 40 min at room temperature for standard coupling steps and 1.5 hr for difficult
coupling steps or for the incorporation of isotope labeled amino acids to allow for a higher
coupling yield (Figure 6). In this step the deprotected amine on the N-terminus of the growing
/ \ ON
O 0NO
0 ~ n+1 H2
0 0 Rn,i 0
Activated Fmoc Amino Acid Resin Linked Peptide Fmoc Protected Coupling Product
Figure 6. Mechanism for the acetylation of an amine by an activated Fmoc amino acid.
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resin linked peptide bonds to the carbon of the Fmoc amino acids HOBt ester linkage generating
the desired amide bond. Note that the resulting product of this reaction is an Fmoc protected
resin linked peptide thereby preventing further addition of the activated amino acid and in turn
polymerization. After the reaction was complete the activated amino acid solution was removed
by rinsing the resin in DMF 3x for 30 sec. This cycle of resin deprotection, Fmoc amino acid
activation, and coupling is then repeated for the addition of each amino acid in the peptide
sequence. Though since the resin has already been exposed to DMF the 40 min resin swelling
step used for the first deprotection can be replaced with a DMF 3x for 30 sec resin rinsing for
subsequent deprotections.
2.2.4 Coupling Reagents
Many activating agents have been developed for the coupling of amino acids including
azide, carbodiimide, and triazolol based reagents. ,17 For these reactions racemization is a
frequently encountered problem. There are three pathways for the racemization of an amino acid:
1) p-elimination which occurs in amino acids with p-side-chains such as cysteine (Cys or C),
lysine (Lys or K), Phe, Ser, and Thr, 2) elimination of the amino acids a-hydrogen, and 3)
generation of an azlactone intermediate (Figure 7). 18-20 For this reason the triazolol based salt
activating agents 2-(1H-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl-uronium-
hexafluorophosphate methanaminium (HATU), HBTU, and 2-(6-chloro- 1 H-benzotriazole- 1 -yl)-
1,1,3,3-tetramethylaminium hexafluorophosphate (HCTU) (Figure 8) were chosen for their high
yield and lower rate of racemization relative to older carbodiimide activating agents such as
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Figure 7. Potential pathways for the racemization of an amino acid under basic
conditions including the deprotination of the alpha carbon (top) and the formation of a
cyclic azlactone intermediate (bottom). The rate of both mechanisms depends on the
acidity of the amino acids a-carbon which varies as a function of the electron-
withdrawing effects of the side-chain and N-terminal protecting group.
dicyclohexylcarbodiimide (DCC) and diisopropylcarbodiimide (DIC). Of these coupling
reagents HATU2 provides the fastest and most efficient coupling with the least racemization
followed by HCTU24 and then HBTU12 ,2'. Though due to the cost of HATU and HCTU there
use was reserved for difficult coupling steps and for the incorporation of isotope labeled amino
acids. Unfortunately HBTU has become difficult to obtain due to the United Nations
reclassifying of HBTU's byproduct HOBt as a class lc explosive.25 In addition since it is the
triazole moiety that is explosive both HATU and HCTU are also potential explosive hazards.
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Figure 8. High yeild coupling agents for the activation of carboxylic acids. Historically
HATU and HBTU were believed to exist as an uronium salt (0 form), as depicted above
for HATU and HBTU, though the current consensus is that there true structure is a
guanidinium salt (N form), depicted for HCTU.26 This finding was significant because
the uronium isomer is a more effective coupling agent then the guanidinium isomer.
These isomers are discussed here for future reference since these coupling agents are
described as both uronium or guanidinium salts in the references provided for this
chapter.
For future work it will be necessary to replace these coupling agents with other chemicals that
offer comparable reactivity and low rates of racemization. One potential family of compounds
for this purpose is ethyl 2-cyano-2-(hydroxyimino) acetate (Oxyma) based coupling agents.27
2.3 Side-chain protection
Choosing an appropriate side-chain protecting scheme is arguably the most significant
component to a successful SPPS synthesis. This step is significant because side-chain protecting
groups prevent unwanted side reactions that diminishes the synthesis's yield, the purity of the
crude product, and may even render a synthesis intractable. 82 8 Of the amino acids used in this
work Asparagine (Asn or N),Glu, Lys, Ser, Thr, and Trp required side-chain protection. A set
of commonly used functionalities for protecting amino acids side-chains are presented in Figure
9. In the proceeding discussion is a description of the protection scheme used for each amino
acid and a brief discussion of the considerations that need to be taken in to account when
incorporating these amino acids into a peptide.
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BzI
Pmc
tBu
Pbf
Boc
OX11
Mtr
Trt
Tos
Figure 9. Commonly used side-chain protecting groups for Fmoc SPPS. Benzyl (Bzl)
protects carboxylic acids, alcohols, thiols, and imidazoles. Tert-Butyl (tBu) protects
carboxylic acids, alcohols, and thiols. Benzyloxy-carbonyl (Boc) protects amines.
Triphenylmethyl (trt) protects carboxamides, imidazoles, and thiols. 2,2,5,7,8-
pentamethyl-chromane-6-sulfonyl (Pmc), 2,2,4,6,7-pentamethyldihydrobenzofuran-5-
sulfonyl (Pbf), 4-methoxy-2,3,6-trimethylbenzene-sulfonyl (Mtr), and 4-toluenesulfonyl
(Tos) protect guanidinium.
2.3.1 Asparagine
Asn is known to undergo numerous side reactions the most common of which is the
dehydration reaction of the Asn p-carboxamide functional group with a carboxyl group to form
p-cyano-alanine (Figure 10).29 This side reaction can be avoided by coupling using an
equimolar quantity of HBTU and HOBt in the absence of a side-chain protecting group30 or by
+ HOV
0 0
+ 0HO
0
Figure 10. Mechanism of asparagine dehydration to create a cyano group. Purple -
carboxamide; Green - cyano.
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a second method, which is used in the present work, of protecting the carboxamide functional
group with an triphenylmethyl (Trt) group.
2.3.2 Glutamic Acid
Glu and Asp both contain a carboxylic acid side-chain and as a result require similar
protecting schemes. In both cases a cyclization followed by reopening of the ring generates two
undesired modified peptide species. As a result the tert-Butyl group is commonly used to protect
H Base N N N
HO H
0 Otu N
O Bu Ok N O N+H
Figure 11. Cyclization and ring opening reaction of a Glu side-chain in the presence of
piperidine to generate a-Glu peptide with a y-piperidide side-chain (Left product) and a y-
Glu peptide with an a-piperidide side-chain (Right product). Green - piperidinedione;
Purple - piperidide.
the Glu and Asp carboxyl group. Though the work of Fields and coworkers,3' has shown that
Asp cyclization was especially common for the sequence Asp(tBu)-Asn(Trt). This is similar to
the TZ2 coupling sequence used for this work Glu(tBu)-Asn(Trt), and although the formation of
the 5 member ring in Asp is more probable then the formation of the 6 membered ring in Glu this
side reaction should still be considered when attempting to optimize the yield for the synthesis of
isotope labeled TZ2 peptides. This reaction is shown in Figure 11 where Glu cyclizes to form a
piperidinediones followed by a ring opening reaction with piperidide to form both an a-Glu
peptide with a y-piperidide side-chain and a y-Glu peptide with an a-piperidide side-chain. In
the case of Asp this side reaction was minimized by the addition of 2,4-dinitrophenol or HOBt to
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the piperidine/DMF reaction solution or using a N-2-hydroxy-4-methoxybenzyl (HbM) side-
chain protecting group on the Asp side-chain. As a result similar strategies should be explored
for the coupling of the Glu residue in the synthesis of cost prohibitive isotope labeled TZ2
peptides.
2.3.3 Tryptophan
Since the amine of the Trp indole side-chain is a secondary amine it typically does not
interfere with the coupling of primary amines on the peptide back bone. Never the less the
indole ring presents pathways for alkylation, oxidation, dimerization and aggregation. As a
result great care should be placed in choosing an appropriate protecting scheme for this residue
that takes into account the neighboring amino acids, composition of the resin, and potential
radical species generated upon cleavage of the peptide from the resin. In the case of TZ2 the
Fmoc-Trp(Boc)-OH was used for coupling Trp residues though for the synthesis of longer
sequences a more careful choice of protecting scheme will be required.
N H O(9K
"...XojCF3
'N '1N
H H
0 0
R7 R1
/ R2  R = H or <
Rs
Figure 12. Alkylation of a Trp side-chain followed by migration of the alkyl group. Green - indole.
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One potential cause for side-reactions in the synthesis of TZ2 is that the nucleophilic Trp
side-chain captures reactive electrophilic species generated during cleavage with TFA.-" An
example for this class of side reactions is demonstrated for the formation of a tertiary amine, a
commonly encountered side-reaction for Trp, by addition of a tert-butyl group to the indole
nitrogen (Figure 12). Here the nitrogen of the indole interacts with tert-butyl-trifluoroacetate, a
strong alkylating agent that is a byproduct in the TFA cleavage of Boc, to form the a Ni"-tert-
butyl Trp derivative. This alkyl group can then migrate from the nitrogen to the 2, 5, or 7
position of the indole ring followed by further alkylation to generate a multitude of undesired
products.3 7 To avoid chemical modification of Trp what is required is a protecting group that
can draw a-electron density out of the indole ring to prevent electrophilic attack and the use of
scavengers to eliminate the reactive byproducts of cleavage (see the section on cleavage).
H H
N N
NH \
H+ d
H4N NH
H
000
H H H H
N N / N N
H N NH H N NH
Figure 13. Acid induced dimerization of Trp side-chains.
Since the hydrophobic core of TZ2 is comprised of four tightly packed Trp side-chains
another alkylation reaction worth noting is Trp dimerization (Figure. 13). Dimerization can
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occur from the acidic conditions in the cleavage cocktail that will be discussed in the next
section. Here the 3 carbon of the indole ring can be protonated generating a positively charged
carbon at the 2 position that undergoes electrophilic attack on a neighboring Trp side-chain. The
resulting charged dimerized species then undergoes an elimination reaction to form the stable
dimer product. As a result minimizing the exposure of the unprotected indole rings in TZ2 to the
harsh acidic conditions found during cleavage will improve the synthetic yield.
Another concern for synthesizing the TZ2 peptide is the oxidation of its indole rings. In
acidic media the indole ring can be oxidized to generate a pink, purple, or yellow solid
depending on the oxidation. Since the TZ2 peptide has a tendency to form a yellow solid care
should be taken in the future to minimize potential oxidation by performing acid cleavage (see
section on cleavage cocktails) under an inert atmosphere and the peptide should be stored cooled
after being lyophilized from neutral solvent.
Finally the Trp indole ring is hydrophobic and as a result the TZ2 peptide which contains
a quarter Trp residues is likely to aggregate during cleavage and HPLC purification. To prevent
this aggregation as well as electrophilic addition a two-step side-chain protection scheme is
required (Figure 14). Depicted in this figure is an example of a doubly protected Trp side-chain
based on the work of Unden and co-workers. 38 In the first step the N-terminus of the Nmbu
protecting group is protonated by TFA which then drives the removal of the acid labile Boc
group. This generates CO2 gas, a tert-butyl cation, and a cationic Nmbu protected Trp. This
charged Nmbu both prevents aggregation by increasing the residues solubility and prevents
electrophilic attack by the tert-butyl cation and other reactive species generated during cleavage.
After HPLC purification the peptide is dissolved in a basic solution to remove the Nmbu group
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via an intramolecular cyclization reaction to generate N-methylpyrrolidone and the desired un-
protected Trp side-chain.
TFA
00
HH
0
+
gas evolution
t
Co2
Base
N
H
HPLC
0
N
Figure 14. Two stage orthogonal deprotection of Fmoc-Trp(Boc-Nmbu)-OH. Blue -
Nmbu.
2.3.4 Lysine
Of the proteinogenic amino acids only Lys has a primary amine as a side-chain functional
group. As a result an unprotected Lys side-chain will compete with the primary amine on the
peptide backbone during the coupling of activated amino acids (Figure 15). In this reaction
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H
2XEmoc- N + Fmoc N'
SH
R
Figure 15. Acetylation of an unprotected Lys to generate a branched product.
an activated amino acid with side-chain and Fmoc protecting groups couples to both the main-
chain and unprotected Lys side-chain of the tethered peptide generating a branched product that
grows along both chains with each additional coupling step. An undesirable side reaction is also
generated in the reverse case where a Fmoc-Lys-OH without a side-chain protecting group is
H2N
Fmoc N Fmoc-Lys-OH
H 0
H2N
Fmoc-Lys-OH Fmoc.. N
Fmoc-Lys-OH
Fmoc-Lys-OH
Figure 16. Polymerization of Lys as a result of coupling in the absence of a side-chain
protecting group. To avoid these side-reactions in the synthesis of TZ2 the primary
amine of Lys was protected with Boc using Fmoc-Lys(Boc)-OH as the
incorporated Lys precursor.
coupled to a peptide. Here the activated Lys continues to be coupled to the resin bound peptide
because of the availability of the unprotected primary amine on the Lys side-chain generating a
polymerized product (Figure 16).
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2.3.5 Serine and Threonine
Ser and Thr side-chains were protected with either a tert-Butyl (tBu) group for unlabeled
amino acids or a silyl group for isotope labeled amino acids. A side-chain protecting group is
employed to prevent acylation of the side-chain which happens readily for the primary alcohol of
Ser and to a lesser extent to the secondary alcohol of Thr during Fmoc SPPS. Thr is found to be
less reactive because its hydroxyl oxygen is sterically hindered and its nucleophilicity is small
relative to the backbone amino group. On the other hand the hydroxyl group of Ser is not
sterically hindered and as a result can compete with the backbone amine for the coupling of
amino acids under strong acylating conditions like those found in Fmoc SPPS (Figure 17). Here
HN
0 N'-N //R N" O1
NN
FmnocO 
RO
Fmoc NH
Figure 17. Acetylation of the Ser hydroxyl group under basic conditions.
the deprotonated oxygen of Ser attacks the central carbon of the ester to form a branched peptide
through the formation of an o-acyl Ser linkage. As a result of this reactivity the isotope labeled
Ser and Thr that were prepared as -C' 8 0' 80H labels both required an additional synthetic step to
protect their hydroxyl side-chain. For these residues a side-chain protecting scheme that would
not act as a source of 160 contamination was required. To do this these side-chains were
silylated using N-methyl-N-(tert-butyldimethylsilyl)-trifluoroacetamide (MTBSTFA) (Pierce
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Protein Research) following the procedure of Madson et al.39 In the case of Ser, 0.139 g of 180
labeled Fmoc-Ser-OH was dissolved in 15 mL of dry dimethylformamide (DMF) or acetonitrile
and the solution was degased using N2. Next 3 mL of MTBSTFA was injected into the reaction
vessel and the reaction was allowed to run for 10 min and then was immediately frozen using
liquid N2 and lyophilized. This step generated a Ser derivative containing both a silinated side-
chain hydroxyl group and the carboxylic acid (Figure 18). The dried product was then
Step 1
OH F3C N O
FmocNN OH Fmoc.N Si
H H
O 0
Step 2
FmocN Fmoc N OH
H H
0 0
EtOH
Figure 18. Silylation of the hydroxyl and carboxylic acid group of Ser followed by the
removal of the silyl group from the carboxylic acid. Here the EtOH selectively removes
the silyl group from the carboxylic acid due to its increased susceptibility of the silyl
ester to nucleophilic attack over the silyl ether.
suspended in hexane (20 mL) and a 1.1 mol excess of dry ethanol was added to selectively
desylinate the carboxylic acid with minimal cleaving of the silyl protecting group. The solution
was again lyophilized and the resulting solid was subsequently purified via recrystallization in
DMF/hexane to generate the final product (see mass-spec in appendix). Finally the sylinated
product was then used immediately for peptide synthesis due to the fact that it on average is only
stable for 6 months at room temperature. 39 It should be noted that although this side-chain
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protecting procedure was used for Ser and Thr it is generally applicable to the protection of
primary and secondary amines, primary and secondary alcohols, and primary thiols. In addition
since the silyl group is labile under mildly acidic conditions it can be cleaved selectively when
used in the presence of the less acid sensitive tBu, Boc, and Trt. As a result this protection
scheme is useful for the generation of cyclic peptides and the synthesis of larger protein
constructs through a convergent peptide synthesis approach.
2.4 Cleavage, Side-Chain Deprotection and Purification
The yield from a Fmoc SPPS synthesis can be significantly reduced by side reactions and
peptide aggregation which can occur during resin cleavage and side-chain deprotection." Both
side-chain protecting groups and resin linkers can form reactive radicals and cationic species that
can attack nucleophilic side chains like those of Cys, methionine (Met or M), tyrosine (Tyr or
Y), and Trp. As a result it is crucial to choose appropriate scavengers and solvent conditions to
optimize yield. Given the variability in the behavior of different peptide and resin combinations
it is best to first test small portions of the peptide bound resin to find the ideal cleavage cocktail
and reaction time.
Before cleavage the resins used for this work were transferred to a filter-frit reaction
vessel and washed with 3x cycles of the solvent series DCM to swell the resin followed by DMF
to clean the resin, and diethyl ether to remove the DMF. Since DMF does not evaporate easily
this final diethyl ether step is required in order to prevent the acid hydrolysis of residual DMF
into formic acid and dimethylamine during cleavage. Once the ether had fully evaporated the
resin was suspended in 4 mls of a cleavage cocktail and was occasionally stirred for 2-3 hrs.
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In the case of Wang and rink amide resin a cleavage cocktail of 95% TFA and 5%
triisopropylsilane (TIPS) was used. For both of these resins this cleavage cocktail
simultaneously cleaves the peptide and removes the side-chain protecting groups. TIPS was
used as a scavenger to prevent side reactions caused by species generated during the removal of
side-chain protecting groups and from the resin linkers. Other commonly used scavengers are
water, 1,2-ethanedithiol (EDT), and triethylsilane (TES) where here the different scavengers are
chosen based on the scavengers efficacy at removing the reactive species generated in a
particular peptide synthesis.
In contrast the 2-chlorotrityl resin was removed under more mild conditions using acetic
acid/2,2,2-trifluoroethanol (TFE)/DCM (1:8:8, v/v/v) which only cleaves the peptide leaving any
protecting groups like tBu, Boc, and Trt attached. In cases where the addition of acetic acid is
undesirable hexafluoroisopropanol (HFIP)/DCM (1:4, v/v) was used as a replacement. Since the
2-chlorotrityl resin allows for selective cleavage and deprotection it was used to synthesize the
protected polymer precursor Boc-GVGVP-OH described by Urry and co-workers.41 It should be
noted that the selective cleavage offered by 2-chlorotrityl resin is also useful for generating
precursors for peptide cyclization or convergent synthesis.
After cleavage the cleavage cocktail was removed and the resin was rinsed with another
lml of cleavage cocktail. This solution was then cooled in and ice water bath before adding
250mls of cold diethyl ether to cause the peptide to precipitate out of solution. This peptide
suspension was then centrifuged at >5 kHz at 00C to remove the supernatant. Next the recovered
crude peptide was dissolved in dilute HCl solution and lyophilized 3x to remove residual TFA.
42,43 In cases where this approach did not yield a precipitate the ether was removed in a rotary
evaporator followed by dissolving the peptide in DCM and removing the solvent repeatedly in a
57
rotary evaporator until the smell of TFA was removed. Finally all peptides were purified using a
C18 HPLC column with a two-phase buffer gradient: (buffer A) 0.1% TFA in H20 and (buffer
B) 80% acetonitrile, 0.085% TFA in H20. The product was then dried and lyophilized 3x in HCl
to again remove TFA followed by lyophilization 2x from D20 (Cambridge Isotope Laboratories)
to remove H20 and acidic protons which is required for subsequent IR studies.
2.5 Preventing amino acid deletion
Amino acid deletion occurs when an amino acid during synthesis fails to be incorporated
into the peptide resulting in the creation of a peptide that is missing amino acids relative to the
desired sequence. Amino acid deletion is problematic because these deletions lower the yield of
the desired peptide and these deleted peptides can be difficult to separate from the desired
peptide using HPLC. As a result monitoring for deletions is crucial for designing the synthesis
of a new peptide.
The two common causes for deletions are incomplete deprotection and incomplete
coupling which originates in both cases from lack of access to the peptides terminus due to steric
hindrance, peptide folding, or peptide hydrophobicity. This risk should be taken into
consideration when synthesizing TZ2 because of its propensity to forms a p-hairpin thereby
blocking amine terminus from being exposed to incoming reagents. This risk should also be
considered when synthesizing peptide sequences longer than 30 amino acids as was the case for
the synthesis of GVG(VPGVG)6.
An effective method for detecting incomplete deprotection is by flowing the deprotection
waist from the peptide synthesizer through a UV spectrometer or by separating the waste using
an HPLC with UV detection. This allows for the quantitative determination of the
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dibenzofulvene/piperidine adduct concentration, generated during Fmoc deprotection, by
measuring its absorption at 301 nm. In the event of low concentrations of the
dibenzofulvene/piperidine adduct the reaction time for deprotection can be increased to allow the
reaction to go to completion. Though because of the risk of alkylation during deprotection it is
best to initially deprotect the N-terminus using a short reaction time followed by rinsing the resin
to remove reactive species before starting a second deprotecting reaction. The process of
optimizing the deprotection time also provides insight into the ideal reaction conditions for the
subsequent coupling reaction since the same issues of steric hindrance, peptide folding, or
peptide hydrophobicity that effect deprotection can also effect coupling. As a result in the event
that a slow deprotection reaction is detected one should then determine the efficacy of the
subsequent coupling reaction.
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Ruhemanns Purple
Figure 19. Creation of Ruhemanns purple by addition of ninhydrin to compounds
containing exposed amines.
An easy method for both qualitatively and quantitatively identifying the extent of
coupling is through the use of a ninhydrin test (also known as a Kaiser test).44'45 The ninhydrin
test detects the presents of free primary amines through the abstraction of the amine nitrogen to
generate the Ruhemanns purple chromophore (Figure 19). Since any successfully coupled site
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will contain the Fmoc protecting group on the N-terminus of the newly coupled amino acid only
unsuccessfully coupled sites will contain a free amine. Therefore by measuring the intensity of
the purple/blue color it is possible to identify the extent of coupling. The ninhydrin test was
performed using a ninhydrin test kit (sigma-aldrich) consisting of three solutions: 80% phenol in
ethanol (w/v), 6% ninhydrin in ethanol (w/v), and 2% 0.001M aqueous KCN in pyridine (v/v).
To perform the test first a small number of resin beads were removed from the reaction vessel
and washed 3 times with dry ethanol. Next these beads were suspended in a mixture containing
3 drops of each solution and heated at 120'C for 5 min. After 5 min the solution was removed
and examined by eye for a qualitative measure of coupling or alternatively it was examined with
a UV-Vis spectrometer to quantitatively measure the extent of coupling. In the case of proline,
a chloranil test is required to detect its secondary amine.46 The chloranil test consists of a 2%
chloranil in DMF solution and a 2% acetaldehyde in DMF solution which are mixed in equal
parts to generate a blue/green color in the presents of free primary and secondary amines. Since
poor solvent exposure and structuring are commonly the cause of difficult coupling steps, for
future work it maybe informative to perform FTIR measurements on resin bound peptides to
detect these potential causes for a failed coupling reaction.
Difficult coupling steps can be driven to completion by either extending the reaction time
or by washing followed by the injection of a fresh solution of activated amino acid known as
double coupling. Alternatively peptide chains with uncoupled N-termini can be capped with an
unreactive functional group to prevent the growth of a deletion peptide. Capping was performed
by washing the resin 3x with DMF for 30 sec followed by suspending the resin in 2 ml of acetic
anhydride for 20 min to acetylate the peptide and finally again washing the resin 3x with DMF
for 30 sec. This capping reaction typically proceeds smoothly because of the small size of the
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acetylating agent allowing it to access hidden amino groups. Finally the capped peptides are
removed durring HPLC purification which has now been simplified by removing deletion
peptides which can have similar elution times as the full sequence. Though it should be noted
that capping should be reserved for difficult coupling because indiscriminant capping can lead to
poor yields.
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Chapter 3
Melting of a p-Hairpin Peptide Using Isotope-
Edited 2D IR Spectroscopy and Simulations
3.1 Introduction & Background
This chapter describes the investigation of the structure of a 8-hairpin peptide using
isotope-edited 2D IR to site-specifically investigate the conformation of its backbone as a
function of temperature. In this mode, the isotope-shifted amide I' band can be used to infer local
structure and dynamics through variations in its vibrational frequency or couplings to other
vibrations. The approach combines 2D IR spectroscopy on a series of peptide isotopologues with
spectroscopic modeling of the peptide's conformers. This pair of tools is used to develop a
picture of conformational heterogeneity across the thermal unfolding transition.
The system that is studied is a 12-residue hairpin peptide tryptophan zipper 2 (TZ2)
designed by Cochran et al.1 It has received significant attention in the literature, with multiple
experimental studies and numerous theoretical treatments. 2-8 Within the last several years, TZ2
has become a benchmark system which is now used in the development of new simulation
techniques. 3',7 9-1 1 The trpzip peptides were engineered with four tryptophan residues arranged
with two side chains on each of the opposing fl-strands that lead to a remarkably stable system
through the favorable perpendicular stacking of the indole rings.' Single-domain peptides like #-
hairpins display conformational dynamics that mirror the folding of larger globular proteins.12,13
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Figure 1. Structure of TZ2 highlighting the SI (green), TT (blue), T10 (purple), and K8
(pink).
Discussion of hairpin folding mechanisms are often guided by two simple pictures: (1) the
kinetic zipper model, in which nucleation of the f-turn is followed by "zipping" of cross-strand
backbone contacts,14-16 and (2) hydrophobic collapse, in which initial clustering by a core of
hydrophobic side chains precedes formation of native backbone contacts.17'18 Extensive
fluorescence 19,20 and IR absorption2 measurements have monitored the kinetics of hairpin
unfolding on 1-10 ps time scales but have not reached agreement on which model best describes
the folding.2 1,23 ,24 Often, folding of this peptide is described within the framework of a two-state
folding model, although its validity and the nature of the two states is unclear.25
Molecular dynamics (MD) simulations of TZ2 folding have provided intricate details
that enrich and challenge these two models, such as partial hydrophobic collapse, fraying of the
terminal residues, ordering of backbone hydrogen bonds, salt bridging, and rearrangements of
the hydrophobic core.1i,26,27 To date, however, the complex set of possible folding pathways
observed by simulations have not led to a consensus view of the folding mechanism.
Experimental evidence has substantiated this complexity and supports a rough free energy
landscape in which there are a number of populated minima." To date, the structural details of
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this heterogeneity have not been experimentally observed, particularly in the peptide backbone.
The key information missing from these studies is specific details of hydrogen bond and side
chain contact formation at a level of detail that can distinguish conformers.
To obtain residue-level structural insight in to the thermal denaturation of TZ2, amide I'
2D IR was used in combination with 13 C and 180 isotope-labeling methods.28-35 Inserting these
labels into the peptide amide group red shifts the amide I' vibrational frequency away from the
main band and provides a spectroscopic probe of the labeled site. Four isotopologues are used to
probe cross-strand contacts and isolate peptide units in the turn, termini, and central region of the
folded structure (see Figure 1).
In the first isotopologue, S1, an 180 isotope is introduced into the N-terminal serine to
probe the stability and fraying of the terminal peptide groups. In the second, T10, an 180 label is
placed on the T10 site to monitor the midstrand contacts. The third, TT, also monitors midstrand
contacts using 13C isotope labels at threonines T3 and T1O of the peptide. The two labeled
amides of TT are hydrogen bound across the fl-strands in the folded structure, and vibrational
coupling between these sites provides sensitivity to the interstrand contacts in this region.3 6
Finally, the isotopologue K8 has a 13C label incorporated into the lysine-8 residue to probe the
thermal disordering of the fl-turn.
The interpretation of 2D IR spectra uses a structure-based spectroscopic model that draws
on MD simulations of the TZ2 peptide in water. The spectral simulations make use of the
extensive set of TZ2 conformers obtained from the MD simulations of Swope and co-
workers," 2 7 and accompanying Markov state analysis of Chodera et al.10 Experimental amide I'
frequency shifts and 2D lineshapes are assigned and interpreted on the basis of calculated 2D
spectra for these Markov states. Spectra are calculated using the local amide I' Hamiltonian that
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describes the amide I' frequency shifts of the peptide groups and vibrational couplings between
these groups.3 7-40 The amide I' site frequencies are mapped onto the local molecular electric
field.3 8,39 ,4 1,42 This describes the red-shifting of the amide I' frequency upon hydrogen bonding
to the peptide unit.
The disorder and local fluctuations of each conformer is reflected in the 2D line shape of
the labeled site.2 43 The diagonal line width of the 2D IR peak is sensitive to the degree of
conformational disorder, whereas the antidiagonal width reflects the fluctuations and time scale
of interchange. Therefore the ellipticity of the line shape is inversely related to the time scale
over which the vibration samples the possible configurations. A large value of the ellipticity
indicates significant disorder in the corresponding local structure. Fast fluctuations in structure
and hydrogen bonded solvent lead to round peaks.44
This chapter establishes a detailed picture of the conformational changes upon
temperature-induced unfolding of TZ2. The isotopologues provide evidence that the termini
disorder as the temperature is raised, and the central region retains cross-strand contacts. Further
this chapter will provide explicit evidence for distinct conformers of the turn, and that the
population of the expected type I' turn increases with temperature. Taken together, these
observations reveal a temperature varying heterogeneous ensemble, whose conformers all
experience thermally induced fraying, but do not unfold into a random coil structure. In addition
to this agreement with previous results, the work shown here gives a level of detail unattainable
with other methods. Isotope-editing provides structural detail at the level of individual amide
groups with higher spectral resolution than FTIR spectroscopy, while resolving picosecond
dynamics that report on peptide flexibility and solvent exposure.
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3.2 Spectroscopic Methods
Temperature dependent infrared absorption spectra of each peptide isotopologue were
collected from 5 to 95 *C in 5 'C increments. The sample cell used in these measurements
consists of -25 uL of the peptide solution sandwiched between two 1 mm thick CaF2 windows
that are separated by a 50 pm Teflon spacer. For temperature control, the cell was mounted in a
brass housing whose temperature was regulated with water from a recirculating chiller. Spectra
were acquired on a Nicolet 380 FTIR spectrometer at 1.0 cm-1 spectral resolution by averaging
64 one-second scans.
2D IR spectra were collected as described in previous publications, 45 with r2 = 100 fs and
the polarization geometry all parallel (ZZZZ) unless otherwise noted. The evolution time, rI, was
scanned to 1.5 ps for the nonrephasing spectrum and 2.0 ps for the rephasing spectrum at 4 fs
time steps, and a rectangular window function was used for the Fourier transform.
3.3 Simulation and Modeling Methods
To simulate 2D IR spectra, five kinetically metastable macrostates were chosen from the
decomposition made by Chodera et al.10 Their work distilled the 3.23 Ps of TZ2 simulation data
by Pitera et al.27 into 40 Markov states that displayed patterns in backbone hydrogen bonds and
side chain packing. Each macrostate, which was comprised of 30 structurally related microstates
with atomistic coordinates, was chosen to represent a different structural model of TZ2.
All MD simulations were performed with GROMACS 3.3.1. 46,47 The simulations of
Pitera et al.27 considered the unblocked peptide, which was fully protonated here (+3 charge)
with chloride counterions. Each of the atomistic structures comprising the macrostate was
subjected to -5000 steps of a steepest descent energy minimization to conform to the OPLS/AA
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force field48 54 using the particle mesh Ewald method to treat long-range electrostatics." The
peptides were solvated in a box of rigid SPC/E water5 6 that extended 1.5 nm from the solute, and
the water was allowed to equilibrate for 10 ps in the NPT ensemble (300 K, 1 atm) while the
peptide was fixed. 57~60 The simulation was continued with no constraints, except on the bond
lengths, for 1 ns of equilibration and 100 ps of data acquisition. Structures were saved every 20
fs to yield 5000 frame trajectories.
For each frame, a Hamiltonian was constructed using the ab initio based models given in
the references40' 4
1
Hs = i (iBW Bi - A 2i B!B!BiBi) + i,JiJ, B!B;
where Bitand B, are bosonic creation and annihilation operators for a vibration at site i. The
frequency of each site and the coupling between sites are given by o>, and Jij respectively. The
anharmonicity, Ai, lowers the energy for double excitation of site i, and was fixed at 16 cm-. The
frequencies and coupling values were calculated as previously described. 40'41 The transition
dipoles for each site had a unit magnitude and were oriented 200 off the CO bond vector in the
CN direction. Where applicable, the sites were isotope-labeled by shifting their frequency 41 cm~
to the red.
The 2DIR spectra were calculated using the numerical integration of the Schr5dinger
equation (NISE) scheme. 61,62 In this procedure the time-evolution matrices needed in the
nonlinear response functions that govern the 2DIR spectra are calculated by solving the time-
dependent Schr6dinger equation. This is done numerically by dividing time into small intervals
during which the Hamiltonian can safely be assumed to be constant. The time-evolution matrix
for the time-independent Schr~dinger equation can then be found for each interval and the time-
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evolution matrices for longer time periods are found by multiplying the matrices for the small
intervals in a time ordered fashion. The resulting spectra were summed over each structure in the
macrostate to produce spectra that reflected the disordered ensembles.
3.4 Amide I' FTIR Spectroscopy Results
FTIR spectra of the TZ2 isotopologues at 25 *C are shown in Figure 2. The peak
maximum of the unlabeled (UL) amide I' band is 1636 cm-1, and there is a prominent shoulder at
1674 cm4 . On the basis of the NMR structure, these bands have previously been assigned to vi
and vii excitonic transitions, delocalized vibrations of the amide backbone in which cross-strand
peptide bonds oscillate in-phase or out-of-phase with one another.36 Twisting of the p-strands
leads to two nearly degenerate vi vibrations located at the turn and midstrand regions of the
peptide, while the v vibration is largely localized at the turn. Because the spectra shown are
taken at pH 2.5, the glutamic acid side chain carbonyl stretch contributes at 1710 cm-1. 63
Changes to the IR spectrum upon isotope substitution are also plotted in Figure 2 for K8,
Ti 0, TT and Si. Isotope-labeling leads to small shifts in intensity and frequency of the vi and vil
bands, and an increase of amplitude to the red of the bands from the isotope-labeled peptide
carbonyl. As seen in difference spectra relative to UL, K8 has a broad (-35 cm-1) increase in
intensity from VK8 = 1585-1615 cm-1, indicating significant structural heterogeneity at this site.
The vi band of K8 narrows and shifts slightly to the blue (1638 cm-1), suggesting that isotopic
substitution significantly rearranges the underlying vi eigenstate composition.
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Figure 2. Equilibrium FTIR spectra are shown for each TZ2 isotopologue at 25 *C and
pH 2.5. Each spectrum is baseline corrected with a linear subtraction, and area
normalized for comparison. Difference data (bottom) are obtained by subtracting the
unlabeled spectrum (TZ2-UL) from each of the spectra. The Si difference spectra is
presented at 2xmagnification for clarity. Arrows have been drawn to emphasize the
isotope labeled peaks.
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In addition to a drop of intensity in the vi band, the T10 spectrum shows a pronounced
shoulder at 1627 cm-1 due to the labeled peptide group. This is a relatively high frequency,
indicative of a single moderately strong hydrogen bond to the oxygen as expected from the NMR
structure. Upon labeling both threonines (TT), spectral loss is observed at 1640 and 1675 cm',
and a broad absorbance gain is observed at VTT = 1610 cm'. The additional red shift of VTT
relative to VT1O reflects the strength of coupling between the cross-strand labeled oscillators of the
VTT band. Labeling both of the threonine residues redshifts the midstrand vi vibration and also
perturbs the high frequency, vil, band. 64 A similar but narrower band was observed at 1608 cm-1
for the TZ2 mutant TZ2-T3A*T10A*.6
The FTIR spectrum of Sl is qualitatively similar to the UL spectrum. The peak
absorption frequency is red-shifted by 2 cm-1 relative to UL, and the difference spectrum reveals
a slight intensity increase between 1590 and 1625 cm 1 . A distinct vsi band is unresolved in the
FTIR spectrum, which indicates that the 39 cm' frequency shift from the 180 label moves
intensity from the blue side of the amide band to the red side, where it remains hidden
underneath the vi band. There is also loss from 1670 to 1685 cm-1 and from 1637 to 1650 cm-1 in
the difference spectrum.
3.5 Amide I' 2D IR Spectroscopy Results
Amide I' 2D IR spectra of the TZ2 isotopologues at 25 *C are shown on the top row of
Figure 3. The spectra show on and off-diagonal features in the amide I' main band between
1630-1690 cm-1, as well as red-shifted features along the diagonal for the isotope-labeled
species. Positive features arise from fundamental (v = 0-1) vibrational transitions, whereas
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negative features arise from v = 1-2 transitions. As described previously,5 the UL spectrum
shows the Z-shaped contour profiles of the excitonic amide I' bands expected for antiparallel
contacts between two strands. The vii band is resolved as a separate peak rather than a shoulder
as in FTIR, and the peak splitting between vi. and vil peaks is 37 cm" in the coi dimension.
Coupling between vi and vil vibrations is observed in the off-diagonal region as ridges that
extend along 03 = 1636 and 1674 cm-.
UL K8 T10 TT S1
1700--
0 1650-
ce)
1600- 
-C-t 25*
1700- -75*C
E 1650 --
1600-_ -
o1 (cm- 1) (01 (cm- 1) '1 (cm- 1) o1 (cm- 1) (01 (cm- 1)
Figure 3. 2D IR Spectra of TZ2 isotopologues at 25 (top) and 75 *C (bottom).
For K8, the most striking feature in the 2D IR spectrum is the observation that the VK8
band is composed of two distinct diagonal peaks: one at 1593 cm-1 (vK8-1) and the other at 1611
cm~1 (vK8-2), with no detectable cross peak between them. (See also Figure 6.) Also, the diagonal
line width of VK8.1 (u= 6.9 cm-) is broader than VK8-2 (U = 4.5 cm'). Strong coupling of the VK8-2
to the vi band is observed as a ridge extending to ci = 1612 cm~1 and (03 = 1650 cm' (Figure 6).
The presence of two shifted peaks for a single K8 isotope-label is an indication of two
structurally distinct subensembles. The 18 cm 4 peak splitting between these features indicates
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that the conformers differ considerably in hydrogen bonding configuration to the K8 peptide
oxygen. The relatively high frequency of VK8-2 indicates a single hydrogen bond to oxygen. The
most reasonable explanation for this observation is that the VK8-2 peak originates in a properly
folded type I' turn in which the labeled oxygen has a single cross-strand hydrogen bond. The VK8.
1 peak frequency is characteristic of a peptide group with two or more hydrogen bonds and a
higher degree of configurational freedom. This suggests a solvent exposed carbonyl that might
be present in a disordered or bulged turn.
For Ti0, the main excitonic band retains the Z-shaped contours of UL, but an additional
sharp peak from the labeled site is observed at coi = (03 = 1630 cmi. Like VK8-2 this high
frequency is suggestive of a single hydrogen bond to oxygen as seen in the NMR structure. In the
2D IR spectrum of the double labeled species, TT, the VTT band is well-resolved at 1602 cm-1,
and the splitting between vi and VTT in the coi dimension is 28 cm-1. The additional red-shift
relative to T1O arises from strong coupling between the Thr3 and Thr1O amides forming a
midstrand vi-like mode.64 Changes to the 2D IR vi band relative to the other isotopologues are
dramatic, including loss of off diagonal structure and a diagonal line width increase of
approximately 21 cm-1. This line width change suggests that the eigenstate distribution of TZ2-
TT is much more heterogeneous than in the other peptides.
The 2D IR spectrum of SI does not show a peak corresponding to the 180 label in the
serine group; however, there are changes relative to UL along the diagonal. The vii band of the
SI 2D IR spectrum, which has a resolvable peak at 1674 cm 4 in the UL spectrum, now appears
as a diagonal ridge to the blue of the vi band. In addition there is a 2 cm' red-shift to 1634 cm-1
and line-narrowing of the vi peak. These observations indicate that the frequency of the UL Si
site energy is relatively high (-1675 cm-1) and that labeling moves the oscillator into resonance
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with the vi exciton band. This would also explain the lack of both a resolvable peak and
interstrand coupling observed between labeled residues in the TZ2 mutant TZ2-S1A*,T1OA*. 6
3.6 Temperature-Dependent Spectra
4-W
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TIO
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Frequency (cm-1)
1600 1650 1700
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Figure 4. Temperature-dependent FTIR spectra of each TZ2 isotopologue taken from 10
to 85 *C in 15 *C increments (pH 2.5). Line color shows progression from cold (blue) to
hot (red).
Temperature-dependent amide I' FTIR spectra of each isotope-labeled hairpin are shown
in Figure 4. Each spectrum shows similar trends with temperature, including the loss of
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amplitude in the vi region and rise of amplitude in the 1660 cm 1 region commonly attributed to
disordered chains. To characterize the overall melting behavior, singular value decomposition
(SVD) of the entire amide I' band is carried out for each data set. For each isotopologue, the data
is well described with the first two spectral components. Spectral changes with temperature are
characterized by the second SVD component, and are shown as melting curves in Figure 5.
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Figure 5. (Top) Second component amplitudes from SVD analysis of the temperature-
dependent FTIR spectra. The inset shows the second component spectra. (Bottom) FTIR
peak absorbance versus temperature. The 12C peak intensities are obtained from the
absorbance within 5 cm-' of the amide I' peak maximum. The integration regions for
other traces are VK81, 1588-1598 cm~1; VK8-2, 1612-1619 cm~1; VTT, 1603-1611 cm~1. Traces
are scaled to overlap between 70 and 95 *C.
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The melting curves are nearly identical and each show slight curvature without a distinct
cooperative unfolding transition. This data is consistent with previous IR, fluorescence, and
UVCD measurements2,4-6 and is identical to the earlier UL data at pH 7.64
In addition to SVD characterization, it is also useful to observe specific spectral regions
within the band. The relative intensities of the isotope-shifted peaks of K8, T1O and TT are
compared with the vi peak of UL in Figure 5. Intensities are obtained by averaging the
absorbance around the peak positions (v = -5 cm ), and are compared by overlaying the curves
between 70-95 *C. This demonstrates that the melting behavior follows the same trends for all
spectroscopic features between 55 and 95 'C. The melting curves for vi peak intensities of all
isotopologues have profiles matching the second SVD component melting curves within 10%.
Similarly, the intensity of the T10 and TT labels both track the SVD melting curves, suggesting
that these curves report on the interstrand contacts in the central region of the peptide. For K8,
the VK81 region changes quasi-linearly with increasing temperature. In contrast, the vK8-2 region is
largely unchanged for temperatures <40 *C. This melting behavior suggests that the VK8-2 peak
reports on peptides with a natively structured turn, while the VK81 peak reports on non-native turn
configurations that show a melting curve similar to that expected for a less-stable or disordered
peptide. The high apparent melting temperature of the VK8-2 peak suggests that the natively
structured turn region is in fact more stable than the rest of the peptide and could account for the
residual backbone structure previously reported over similar temperatures.
Temperature-dependent changes to the 2D IR spectra of each isotopologue can be seen
by comparing the 25 and 75 *C spectra shown in Figure 3. Along the diagonal axis ((>1 = cos),
spectral shifts track those observed in the FTIR data, and spectral features broaden along the
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antidiagonal axis with increasing temperature. This analysis focuses on the center frequency,
amplitude, and 2D lineshapes of the isotope-labeled features. The line shape can be characterized
by their widths parallel and perpendicular to the diagonal axis. The diagonal line width (a-)
reflects inhomogeneous broadening that originates in static structural disorder on the time scale
of the experiment (-2 ps). Antidiagonal widths (F) report on rapid frequency shifts that originate
in subpicosecond peptide-solvent interactions and structural fluctuations. The relative
magnitudes of these linewidths, or ellipticity E = (o2 - F2)/(2 + F),44'65 measured as a function
of temperature can be used to interpret changes from static disorder to dynamic disorder due to
increasing structural flexibility and solvent exposure.44
Spectral changes to the UL 2D IR data are similar to those reported earlier at pH 7, which
were interpreted as fraying of the termini and an intact turn at all temperatures. The antidiagonal
line width grows with temperature for both of the p -sheet modes in the 2D IR spectrum (data not
shown). The full width at half-maximum (FWHM) of the vil band is only -2.0 cm-1 larger than
that of the vi band at 15 0C, but the slope of the line width increase versus temperature of vil is
twice that of the v.i band.
Thermally induced spectral changes to the VK8 peaks can be seen more clearly in Figure 5.
As the temperature of the system increases, the spectrum responds both to structural
rearrangements and shifting populations between native and misfolded ensembles. The center
frequency of the VK8.1 and VK8-2 bands does not change with temperature, but the amplitudes of
both peaks decrease. In addition, the VK8.1 intensity decreases with respect to the VK8-2 peak,
indicating that the native turn is more stable than the disordered turn. Linewidth changes to the
TZ2-K8 spectra are consistent with those of the unlabeled hairpin (Figure 7). The slope of the
line fit to the FWHM of the 12C vi band (0.058 ± 0.012 cml/*C) is twice as large as the
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corresponding slope of TZ2-UL (0.020 ± 0.006 cml'/C). For the VK8.1 and vK8-2 peaks, the
FWHM measurement is noisier due to lower signal strength. However, the line width of the high
frequency peak, VK8-2, does not display a significant slope with temperature, indicating that the
homogeneous broadening does not increase significantly with temperature. The limited
resolution of the VK8 peaks prevents a quantitative description of the diagonal line width.
However, in the spectra shown in Figure 6 there does not seem to be any clear sign of diagonal
peak broadening with temperature.
K8 TIO T3T10
015 OC
1640
o1620-K-
160
1600 1640 1600 1640 1600 1640
Figure 6. Temperature-dependent 2D-IR spectra of isotope-shifted peaks in K8, T10, and
TT. Contour lines are plotted as a percentage of the amide I' maximum at the respective
temperature. Twenty seven evenly spaced contours are drawn from -18 to ±18% (K8), -
80 to +80% (T10), and -35 to +35% (TT).
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Figure 7. Lineshape analysis of temperature-dependent 2D IR spectra of K8 and TT.
Antidiagonal line width (FWHM) for (A) K8 and (B) TT. (C) Ratio of K8-2 to K8-1 peak
volumes. (D) Ellipticity of isotope-shifted peaks. The data for K8-2 has been upshifted by
0.2 for clarity.
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Together, these observations support the idea that two bands are reporting on
subensembles of peptides for which the relative population shifts with temperature, but the line
width properties remain relatively constant. The presence of two isotope-shifted peaks in the turn
may reflect two distinct conformational states of the peptide; however, from the K8 measurement
alone one cannot rule out additional states that have the same type of solvent exposure in the
turn. Of course, conformational dynamics will be present that interconvert these turn structures.
Not surprisingly, if a two state analysis is applied to this exchange of conformers (K8-1 to K8-2),
one finds that the temperature dependence does not follow van't Hoff behavior (Figure 7).
However, if one restricts the analysis to the high temperature range between 45 and 75 *C for
which most spectral features shift in concert, one finds that AHi 2 = 20.2 ± 2.8 kJ/mol.
Thermally induced spectral changes to the VTT peak are emphasized in Figure 6. Similar
to the VK8 peaks, the maximum of the positive diagonal VTT peak does not shift appreciably with
temperature. Instead, the VTT - vi peak splitting increases from 26 cm' at 15 'C to 34 cm' at 85
*C, which results from the blue-shift of the vi peak. The relative intensity of the isotope-shifted
peak also drops, going from 40% of the band maximum at 15 *C to 20% at 85 *C. This decrease
in intensity is partially ascribed to a loss of coupling between isotope-labeled amide groups and
the 12C amides. The shape of the VTT peak also changes drastically with temperature, going from
a diagonally elongated peak to a symmetrically distributed peak as the temperature is raised.
From 15 to 75 "C, the antidiagonal VTT FWHM increases more than 2.0 cm 1 , and the VTT
diagonal width decreases by a similar amount over the equivalent temperature range. These line
width shifts show that the region around T3 and T10 are relatively rigid at low temperature but
experience increased configurational fluctuations of the peptide groups and surroundings as the
temperature is raised. Yet, on average the frequency of the VTT peak and magnitude of
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crossstrand coupling remains unchanged from lower temperatures. These disordering pathways
are consistent with the fraying transition described in previous hairpin simulations.
1
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3.7 Simulation Results
To better interpret how the observed amide I' spectral features report on peptide
conformation, structure-based modeling of 2D IR spectra was applied to five sets of TZ2
conformers drawn from the Markov state analysis of Chodera et al. 10 Each configuration chosen
for the spectral simulations should be viewed as an ansatz from which structural features that
play an important role in determining the spectroscopy can be identified. Conformational
disorder for each of these Markov states is shown in Figure 8 and one representative structure
from each state chosen is shown at the top of Figure 9. In Figure 8 a visualization of these states
is presented showing 30 overlapped structures of the peptide. These backbone visualizations
serve to characterize the amide group orientations and conformational disorder of each state, and
the lower right panel illustrates the packing of tryptophans for each state. The set of five
representative Markov States, shown in the figures below, were used to create structure/spectrum
correlations. Here the number identifying each state refers to the designation in appendix for
McDonald & Jorgensen 1998.68
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Figure 8a. Folded (FO, 250851) is a well-ordered ensemble that has an average of four
backbone hydrogen bonds, which correspond to those in the NMR structure.' The Si, T3,
K8, and T1O carbonyls are all oriented for cross strand hydrogen bonds, and all four
tryptophan side chains are packed to one face of the peptide.
K8
T10
Figure 8b. Bulged Turn (BT, 214369) is a compact coiled structure with a well-
solvated, bulged turn region and an average of one cross-strand hydrogen bond that
appears near the strand termini. This state contains Si, T3, K8, and Ti0 peptide
carbonyls that are solvent exposed, and tryptophan side chains make rare contacts.
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Wr
Figure 8c. Disordered (SR, 271154) is a disordered ensemble whose common feature is
a bulged turn and an average of one backbone hydrogen bond with a misaligned registry
near the C terminus. Tryptophans are poorly organized.
T3
T10
Figure 8d. Frayed (FR, 11131) has a compact properly formed type I' turn region with
an average of two backbone hydrogen bonds but disordered strand termini. The T3 and
T10 are oriented toward the opposite strand, and tryptophan side chains are disordered.
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I&
IFigure 8e. Extended Disorder (ED, 64336) is an extended and well solvated state with
substantial disorder and rare backbone hydrogen bonds.
As a first point of contact to experiment, electric field mapping was used to calculate
histograms of. amide I' site energies for the 11 peptide units of the backbone. The red-shift is
primarily sensitive to hydrogen bonding to the oxygen site. Histograms for sites Si, T3, K8, and
T10 are shown in Figures 10 and 11. It is apparent that the distribution of site energies for site T3
and K8 vary in such a way that the mean frequency is unique for the FO and BT conformers. On
the other hand, Si and T10 appear to be insensitive to conformation. Time-correlation functions
for the site energy showed biphasic behavior, with a picosecond component attributed to solvent
induced dephasing, and a longer component assigned to sampling of backbone configurations.
The longer decay time varied from -50 ps for Si, T3, and TIO to >200 ps for W4 and K8.
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Figure 9. 2D IR spectral simulations of all five TZ2 isotopologues studied for five
different conformational ensembles. One representative structure for each conformer
macrostate is presented. Simulations of K8 for the spectral region (>1 < 1650 cm~' have
the amplitudes scaled by a factor of 1 Ox.
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Figure 10. (Top) Isotope-labeled TZ2 amide I' site energy distributions for the five
Markov states. (Bottom) Distribution of calculated amide I' site energies grouped by
number of hydrogen bonds. A linear fit to the mean value gives o = 1645.7 cm' - 16.3 x
(no. of CO H-bonds).
The modeling of all conformers provides a general relationship between the amide I' site
frequency and the hydrogen bonds it participates in. This modeling found that a hydrogen bond
(HB) of an amide carbonyl to protein gives about the same red shift as a hydrogen bond to water.
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(For this chapter, a HB is defined by the hydrogen bond distance and angle: rx... >0 < 4.5 A, ox.
->HO < 350). However, when an amide group is fully solvated by water, it has the ability to form
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multiple HBs, giving a larger average red shift. From analysis of both types of HBs, on average,
one HB leads to an 11 cm- red shift, however the dispersion in this relationship (o = 25 cm')
leads only to a modest correlation (p = -0.50). These results can be compared with the results of
ab initio calculations on isolated clusters, which reveal a 20 cm' red-shift for each HB to oxygen
and an additional 10 cm' red shift for hydrogen bonds donated by the peptide N-H.69
For each of these five conformers, infrared spectra were simulated for all five
isotopologues studied. Simulated FTIR and FTIR difference spectra for each structure are shown
in Figure 12. In general qualitative similarities exist between several of the experimental and
simulated spectra, which are discuss here in terms of peak positions, amplitudes, linewidths, and
lineshapes. The simulated 2D IR spectra of the unlabeled peptide for FO, BT, and FR conformers
each display two diagonal peaks and Z-shaped contours that resemble the experiment at low
temperatures. For the disordered SR state, two bands are also resolved although in this case, the
high-frequency band carries most of the intensity. Limiting the simulation only to a specific
structure with +1C slipped registry and 4 hydrogen bonds leads to a spectrum similar to BT, see
Figure 13. For the disordered ED state, the amide I' band has little structure and reflects the
diagonally stretched resonance of an inhomogeneous line shape.
As expected, each of the five K8 simulations gives rise to one resonance for the labeled
site, although the peak position and line width vary with conformation. In particular, there is a
correlation between the orientation and solvent exposure of the K8 amide group and the
frequency of the isotope-shifted peak. In the case of FO and FR states each have a K8 amide
group oriented so that its carbonyl oxygen forms a cross-strand hydrogen bond with the W4
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amide proton, as expected for a type I'# turn. In their calculated spectra, the VK8 peak is split
from the amide I' maximum by 25-30 cm', and the diagonal line width is a compact 5-6 cm-. In
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Figure 12. Simulated FTIR and FTIR difference spectra for isotopologues of all Markov
States.
addition, a distinct cross peak is observed between the VK8 and vi bands in the calculated spectra
for these states. For each of the other structures (SR, BT, and ED) the K8 oxygen has higher
water exposure on average, although with higher variance in hydrogen bonds formed. The VK8-Vi
amide I' peak splitting for each of the corresponding spectra is 30-36 cm', and the label
resonance has distinctly broader diagonal linewidths of 10-14 cm 1 . The calculated BT spectrum
shows the largest shift and line width. The observed differences can be attributed to variation in
hydrogen bonding to the K8 carbonyl. Fully solvated carbonyls will on average participate in
two hydrogen bonds to water, as opposed to one cross-strand hydrogen bond in the case of
properly folded P turns. For the K8 carbonyl, it was found that each hydrogen bond contributes
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on average a 16 cm~1 red shift in amide I' frequency; however, the correlation between hydrogen
bond number and red-shift is mild (p = -0.53). Therefore the solvent-exposed K8 conformers
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Simulations of the 2D IR spectra for the NMR structure of TZ2.
Figure 13. 2D IR spectral simulations of TZ2 isotopologues for specific conformations.
should exhibit an additional red shift relative to FO, but the conformational disorder and
fluctuations in peptide backbone and water hydrogen bonds will also lead to a larger
inhomogeneous width. Based on these observations, one can conclude that the vK8.1 peak
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represents peptides with non-native turns, and the high frequency VK8-2 peak reports on structures
with native type I' f-turns.
During simulations of the IR spectra for the NMR structure at pH 2.5, a correlation
between the K8 site frequency and two distinct E5 side chain configurations was observed.
Specifically, two configurations of the glutamic acid side chain and backbone dihedrals that
differed in O(K8) - > 6C(E5) separation by 6.1 and 6.8 A were predicted to be observed with
frequency splitting of 12 cm-1. The observation of these two conformers required a protonated
form of the glutamic acid (pKa 4.6). This was ruled out as an explanation of the two K8 peaks in
experiments because the amide I' resonances in FTIR and 2D IR spectra exhibit no pH
dependence between pH 2.5 and 7.
The T10 peptide carbonyl adopts a variety of conformations in the Markov states
simulated. In the case of the FO and FR states it is oriented for a cross-strand hydrogen bond, for
BT it is entirely solvent exposed, and for SR and ED it samples a variety of configurations. In
simulated spectra conformers with solvent exposed T10 carbonyls give rise to a structured
excitonic spectrum and a red-shifted and spectrally distinct T1O peak, whereas the internally
hydrogen bonded site gives a peak merged with the excitonic band, as observed in experiment.
For the SR and ED states, the intensity of the labeled transition is greatly diminished over the
intense band seen in the completely water-exposed state. Of all simulations, the FR state
corresponds best to the low temperature experimental spectra. These observations demonstrate
that the T 10 experimental spectra provide evidence of a T10 carbonyl that participates in a single
cross-strand hydrogen bond over the temperature range sampled.
For 2D simulations of TT, it was found that all conformers except ED have a resolvable
red-shifted peak arising from the TT label. In the case of the disordered states SR and ED, there
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is little change in the spectrum between the Ti0 and TT simulations, which reflects the limited
correlation between the positions of their T3 and T10 peptide units. For the FO and FR
conformers, which have close T3-T10 contacts, a distinct VTT peak is observed although the T10
spectrum showed no distinct T10 isotope-shifted feature. This is a result of the additional redshift
of the VTT band as a result of T3-T1O amide I' coupling, which varies between 6-7 cm' for the
FO conformers and leads to a VTT - Vi splitting of >30 cm'. Comparing the T10 and TT 2D
spectra for the BT state shows few differences besides additional inhomogeneous broadening of
the VTT transition. Each of the simulated spectra containing proximal T3 and TiO sites bear
similarity to the experimental spectra, but those that compare favorably to the calculated T10 and
TT spectra are FR and FO. Finally, the intensity of the simulated VTT feature scales with the
strength of coupling between the two threonine sites. These observations show that contacts
between strands in the central region of the peptide exist throughout the temperature range
studied. In addition, out-of-registry structures are not significantly populated in the equilibrium
conditions observed here.
Simulations of the Si spectrum were used to address the lack of a distinct peak for the
180 peptide site, and the shifts in intensity and line shape seen in FTIR and 2D IR spectra. In
general, for the Markov states studied, the Sl site is protected from the solvent, because the
serine side chain and terminal -NH3+ both prefer to be oriented to the solvent, and because
tryptophan side chains interfere with water penetration to the S1 carbonyl. Thus, the Sl site
energies are generally high regardless of conformation. The FO state has many intact SI-W I1
hydrogen bonds, the SR has Sl carbonyls that experience a range of solvent and side chain
environments, and the FR is the most solvent exposed.
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The experimental (Si -UL) FTIR difference spectrum indicates that intensity is lost at
1675 and 1640 cm-1 upon Si labeling. Simulations of this spectrum for various conformers
shows that this characteristic double peak loss feature matches those observed in the FO state,
whereas other states show a single loss feature (see Figure 12). Cross-strand hydrogen bonding
between the S1 and W 11 in the FO state leads to strong coupling across the fp-strand and a low
frequency vi-like mode which is decoupled from the rest of the band and shifts upon 180 isotope-
labeling. However, the high frequency loss features in FTIR and 2D IR are also present in BT,
SR, and FR, which have high site energies and weak coupling to the remaining peptide units. 180
labeling shifts the SI vibrational frequency for each system from very high energies (>1700 cm-
1) in the unlabeled spectrum to frequencies just to the blue of the vi. The distribution of S1
configurations available in these conformers suggests that the S1 site is generally disordered at
all temperatures.
3.8 Discussion and Conclusions
Spectral changes to the amide I' band of TZ2, using four isotopic substitutions to probe
the fl-turn (K8), the N-terminus (S), and the midstrand region (T1O and TT) of the hairpin
structure, provide a site-specific description of the thermal denaturation of this fp hairpin. The
13C' label at K8 reveals two unique turn geometries, the type I' p-turn observed in the NMR
structure (VKs-2), and a less populated disordered or bulged loop (VK8.1). Structural disorder within
the VK8-2 band does not increase significantly with temperature, which shows that the fl-turn
structures remain well-ordered. The VK8.1 population in contrast does decay with temperature,
indicating a relatively unstable loop. The hairpin retains interstrand contacts in the midstrand T3-
T10 region over the entire temperature range studied as evidenced by the consistently high
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frequency of the T10 resonance and coupling-shifted TT resonance. Unlike vK8-2, the 2D VTT line
shape changes from a heterogeneously broadened peak to a more symmetric homogeneously
broadened peak, indicating that this region experiences an increase in the magnitude of
picosecond fluctuations in the peptide, its internal contacts, and immediate surroundings.
Spectroscopy of the N-terminal serine group amide group puts constraints on the possible
conformations of the termini. From these observations, this chapter has shown that SI is free to
explore a large configurational space, relative to the other labeled residues. These vary from
structures in which the S1 amides are hydrogen bonded to the W 11 amide to structures in which
there is no interaction with the other peptide amides.
Additional information on the TZ2 turn is available from recent experiments on turn
2,70labeled TZ2-G7* and spectroscopic simulations based on the NMR structure. An isotope-
shifted peak was well-resolved in the room temperature 2D IR spectrum, and shown to be
consistent with a solvent exposed amide groups. In addition, 1 ps waiting-time 2D IR data
revealed cross peak structure to the G7* site that was attributed to different solute-solvent
substates. These observations are consistent with the assignments presented in this here, and can
be explained with the conformer simulations. The dominant isotope-shifted peak is at 1595 cm',
reflecting the high degree of solvent exposure of the G7 carbonyl observed in the FO structure.
Other conformers studied have lower solvent exposure and considerable disorder, leading to
higher transition frequencies, as observed in experiment.
The picture that emerges from this data provides a detailed view of a heterogeneous
thermal fraying process. The 25 *C state includes roughly 60% conformers that retain most of
the cross-strand contacts seen in the NMR structure, whereas others have midstrand hydrogen
bonding contacts and a bulged loop. As temperature is raised, the ends fray for all molecules,
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becoming more solvent exposed, and introducing more disorder into the central contacts of the
hairpin. Contacts remain within the central region of the hairpin, but on average the turn is more
ordered. No idealized unfolded state with fully solvated backbone is observed. These results add
structural insight to the building body of evidence that TZ2 folding is heterogeneous.1 1"19'71
Further, the data presented in this chapter provides a point of reference for testing the
conformational variation and energy landscape observed by TZ2 MD simulations.7,10,11,27,72
Curiously, the type I' turn appears to be favorable at high temperature. One can
rationalize the origin of this apparent annealing by comparison of Markov states. The frayed
state provides the possibility of packing W4 and W9 side chains about the turn which is not
possible with the bulged turn. As such it appears that the desolvation entropy for water about
tryptophans plays a key role in determining the relative stability of these conformers. This
counterintuitive shift of turn stability could be compared with cold-denaturing transitions
attributed to hydrophobic hydration. 73
What can be said about the TZ2 and the folding pathways of p hairpins? While it was
originally assumed that there is a choice to be made between zipping 20 and hydrophobic
collapse,74 it appears that both of these processes play crucial roles for the folding of TZ2. For
TZ2, the simulations seem to be in agreement that folding proceeds from the turn to the termini,
but that this "zip-out" process involves both contacts between W4 and W9 and turn hydrogen
bonding contacts. 9,72,7 This hybrid zipper type model 2 6 ,7 6 explains the varying experimental
views that both the nature of the turn and the hydrophobic packing4 are critical to hairpin
folding.
The observations presented here closely match those of Gao and co-workers, 3 who
recently performed MD simulations of the sequence dependent temperature-dependence of pl
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hairpin folding. Temperature-dependent studies of TZ2 unfolding indicated that there was a
propensity for the HB closest to the turn (E5-G7) to form as the temperature is raised, even
though other HBs tended to rupture. These authors used clustering analysis of states during TZ2
folding to argue that the folding mechanism from an extended state is dominated by a zip-out
mechanism in which the turn forms first, although they do identify bulged configurations along
the folding path. 3  Hydrophobic clustering and cross-strand HBs were favorable at low
temperature in the central region, whereas the frayed state was favored at high temperature.
Recently there have been several studies of peptide structure with isotope-labeled 2D IR
spectroscopy that demonstrate the capabilities of this method for insight into backbone
conformation and hydrogen bonding environment. 28,30,31,77 This work indicates the potential of
the method to unravel systems with conformational heterogeneity and disorder. With an
appropriately large set of trial conformers and increased improvements in spectroscopic
modeling, one should be able to use self-consistent modeling of multiple isotopologues to
provide a detailed picture of the global range of conformations adopted by the peptide.
Experimentally, one can also imagine that for cases such as TZ2, 3D IR spectroscopy on
multiply labeled peptides can provide a higher level of conformational detail by correlating the
local structural environment between multiple sites of the same peptide. Such experiments
provide an avenue to characterize conformational heterogeneity of rapidly exchanging
conformers of proteins and peptides in folded and disordered states.
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Chapter 4
Identifying Residual Structure in Intrinsically
Disordered Systems: A 2D IR Spectroscopic
Study of the GVGXPGVG Peptide
4.1 Introduction
In this chapter the role that the amino acid preceding a PG turn plays in determining the turn
structure of an intrinsically disordered peptide is investigated. The XPG sequence is commonly found in
fibrous and elastomeric proteins, in which X influences their structural and mechanical properties.
Examples include collagen (X=Pro)', elastin (X=Val)2, mussel byssus (X=Gly) 3, dragline spider silk
(X=Gly) 4, and wheat glutenin (X=Gln)5 . To better understand the structure and folding of a XPG peptide
turn, the side chain size of proline's N-terminal amino acid was modulated for the disordered peptide
GVGXLPGVG, where X = Gly, Ala, or Val. These peptides were characterized with amide I' 2D-IR in
combination with structural modeling of spectra6 -.
Unlike other proteinogenic amino acids, the tertiary amide structure of proline changes the amide-
I vibration of the peptide linkage preceding proline in sequence. The three heavy atoms bound to its
nitrogen give proline's amide I' vibration a larger reduced mass, shifting it to a lower frequency. This
frequency shift largely decouples proline's amide I' vibration from the amide I' vibrations of its
neighbors, moving its resonance to a predominantly background free region on the red side of the
absorption spectrum. As a result, proline amide I' spectroscopy can also be used as a local probe of
protein structure. Because the proline amide I' vibration has almost all C=O stretch character, a frequency
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shift of the proline amide I' vibration is either predominantly the result of a change in hydrogen bonding
to the amide oxygen or other changes in the electric field experienced by the amide C=0. (For
spectroscopic reasons, the main chain amide or carbonyl preceding proline will be referred to as the
proline C=O, although it derives from the proceeding amino acid). With the help of a recently
parameterized structural model for proline IR spectroscopy,8 it is now possible to exploit this intrinsically
local vibration and use it as a sensitive probe of proline turn structure.
4.2 Experimental spectra
The series of model peptides studied here differ in the volume of the side-chain on the N-terminal
side of proline. The peptide with the smallest volume in the series is Gly with a volume increase of A(X-
Gly) = 25.1 and 75.3 A3 for X = Ala and Val respectively.9 The resulting change in turn conformation is
detected in the experimental infrared spectra as a red shift of the low frequency proline amide I' vibration
with increasing side-chain size, from Gly = 1625 cm' to Val = 1614 cm' (Figure 1). The features in p-
turn peptides at 1670 cm' and 1640 cm' are commonly assigned to the parallel and perpendicular bands
of an antiparallel P sheet.10 Since proline's amide I' vibration is only weakly coupled to the remaining
amide units of the peptide, the observed frequency shift primarily reflects variation in hydrogen bond
configurations to the oxygen of the C=O moiety preceding proline.
As a rule of thumb for a time-averaged observation, the amide frequency red shifts by roughly 16
cm' for each hydrogen bond accepted, and on average the oxygen can accept up to two." Therefore the
shifts in Figure 1 encode considerable changes in turn hydrogen bond configuration and possible changes
in solvent exposure.
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Figure 1. (Top) FTIR and (Bottom) 2D IR spectrum of GVGXLPGVG at T = 10*C in pH
= 1.0 DCl in D20. The proline resonance frequencies are Gly: 1625 cm 1 , Ala: 1619 cm~,
and Val: 1614 cm~1. Maximum optical densities were 0.23-0.25. Contours for all 2D IR
surfaces presented in this paper are plotted from -1.0 to 1.0 in equally spaced steps of
0.08.
To perform these experiments samples for FTIR and 2D IR spectroscopic measurements were
first dissolved in D 20 and lyophilized in order to exchange the acidic hydrogen's of the peptide for
deuterium. The resulting dry deuterated peptide was then dissolved in a pH = 1.0 DCl in D20 solution at
a concentration of 18.2 mg/ml. No aggregation was observed in the 2D IR spectra at this concentration,
in addition for the Val peptide no spectral changes were observed over a range of 10 to 50 mg/ml. Next
the sample was then placed between two 1mm thick CaF2 windows separated by a 50pm Teflon spacer
creating a ~-25 pL sample volume. The FTIR spectra were collected on a dry air purged Nicolet 380
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FTIR spectrometer at a spectral resolution of 2.0 cm"' and averaged for 64 one-second scans. The 2D IR
spectra were collected as described previously using 100 fs broad band mid-infrared pulses and a ZZZZ
polarization geometry 2 . This data was collected using a waiting time ofT2 = 150 fs and a T1 evolution
time that was scanned to 3.1 ps for the rephasing spectrum and 2.5 ps for the non-rephasing spectrum in 4
fs time steps. All experiments were performed at pH = 1.0 in order to eliminate the -COO~ stretch at
1590 cm-1 by deuterating the C-terminus creating the -COOD stretching vibration at 1722 cm~1. It should
be noted that the findings presented here are consistent with spectra measured at neutral pH (Figure 2). In
the case of Figure 2 the 2D IR data was collected in a ZZYY polarization geometry at both pH = 1.0 and
7.0 for reference with no other alterations to experimental conditions.
1685 p H =1 pH= 7
'1665
~1645-
831625/
1605
01 (cm-1) 0o (cm- 1)
Figure 2. Val peptide 2D IR collected in ZZYY polarization at T = 10*C in a (Left) pH =
1.0, DCI in D20 solution using T2= 150 fs, and in a (Right) pH = 7.0, 50 mmol phosphate
buffer solution using T2 = 0 fs. Changing the solvent conditions produces the appearance
of on-diagonal broadening for the proline peak, a blue-shift of the main amide I' band,
and a reduction in the off-diagonal line width. The change in the appearance of the
proline peak results from the generation of the COO moiety upon changing the pH,
creating a peak at 1590 cm'1 from the COO asymmetric stretch. The blue shift of the
main amide I' band and the reduction in the off-diagonal line width observed at pH = 7
are likely due to the addition of buffer salts which produces a similar effect in pH = 1.0
samples.
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4.3 Modeling and Simulations
To extract information on peptide structure from the infrared data, FTIR and 2D IR spectra were
calculated from molecular dynamics (MD) simulations of the three peptides using a similar mixed
quantum-classical model as was presented in chapter 3. A vibrational Hamiltonian was constructed for
every MD snapshot by employing a Hamiltonian of the form":
N N N
H(t) = W[(t)bbi - y bIbtbibi] + J ;(t)bbi +11y (t) e E(t)[b7 + bi]
i=1if i=1
Here the summations run over the amide I' sites in the peptide where for any amide site i, b and bi are
the Bosonic creation and annihilation operators for the amide I' vibration, &o (t) is the frequency, Ai(t) is
the anharmonicity, Jij (t) is the coupling between the ith and jth site, E(t) is the applied laser field and pi
is the transition dipole. For this scheme the Hamiltonian was considered to be constant for the 10 fs time
intervals between successive saved structures of a MD trajectory.
Amide I' site frequencies (wi) for secondary amide groups were calculated with a Stark effect
based approach using the electric field and its gradient on the C, 0, N and D atoms6 . For the proline
amide unit the field components were considered on the C, 0, N and C8 atoms8 . Next, frequency shifts
and couplings due to through bond effects with neighboring amide units were determined using
Ramachandran angle based look up tables7' 8 . The non-nearest-neighbor couplings were then calculated
using a transition charge coupling scheme'' 8 The anharmonicity needed for describing doubly excited
states was again set to a value of 16 cm-1 for all amide units 13 . A 14 cm' systematic red-shift of the
frequencies of all amide units except proline was used in this model because the frequency maps
developed for the secondary amide units overestimate their frequency by the same amount.8 Finally an ad
hoc vibrational life time (1 ps) was used in the spectral simulations14 . The total time interval for
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calculating a sample for an FTIR spectrum was 2.5 ps and for a 2D IR spectrum it was 5 ps ( 1 1=2.5 ps,
T2=0 pS, T3=2.5 ps, where tI, T2 , and T3 are the time delays between the pulses).
These spectral calculations were performed on eleven structurally distinct initial configurations
that were selected from a 200 ns MD trajectory of the Val peptide carried out previously."" These
initial configurations are representative of the main structural and dynamical motifs observed, including
extended and collapsed states, and a variety of PG turn configurations. This judicious choice of initial
conformations makes it possible to use rather short simulations for computing 2D IR spectra of local
structural motifs since the picosecond time scale of the experiments is far shorter than the (multi-
)nanosecond relaxation times of the peptide. These eleven configurations were then mutated to obtain the
initial configurations of Ala and Gly variants. Next, MD simulations in NVT ensembles at 300 K were
performed on these conformers using Gromacs-4.0.7 and an all atoms OPLS force field for the peptide
which was solvated in a box of TIP3P water19-21. D20 was used to reproduce the experimental conditions
and all acidic protons of the peptides were deuterated. These simulations were carried out with 2 fs time
steps and the LINCS algorithm was used to constrain all bond lengths22 . For temperature coupling the
Nose-Hoover thermostat was used23 24 . The reaction field method was used to treat the long range
electrostatic interactions with a cutoff of 1.4 nm. The length of each trajectory was 2.5 ns, where
snapshots were saved every 10 fs yielding 2750000 conformations for each peptide studied. The
simulations of these disordered peptides sampled a variety of configurations, including variations in turn
structures, fraying or extension, and side-chain packing. Although these simulations may not provide a
complete sampling of all configurations, it is extensive enough to provide a diversity of trial structures by
which to create structure/spectrum correlations.
Turn conformers were distinguished based on hydrogen bonding patterns to the X carbonyl
preceding the proline. Six hydrogen-bond bins were investigated: 0/0, 1/0, 0/1, 1/1, 2/0 and 0/2, where
the first digit corresponds to the number of hydrogen bonds the proline CO accepts from other amide
groups
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1/0 2/0 1/0
1/0 1/0
0/0 0/0 0/0
1/0 2/0 1/0
Figure 3. The images above show representative structures from the 1/0 and 2/0
hydrogen bonding bins selected from the Val NM trajectories used in this work.
Hydrogen bonds are labeled for a single selected structure which is fully represented, with
an ensemble of similar structures (peptide backbone only) is shown in gold for
comparison.
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Figure 4. Ramachandran plots for the four central turn residues (X5 P6G7V8 ) for the 1/0
and 2/0 hydrogen bond bins. Each plot was generated by culling structures based on
hydrogen bonding criteria from 22 nsec of MD simulations for each of the three peptides
GVGVPGVG, GVGAPGVG, and GVGGPGVG. Culling was performed using the
g_hbond utility implemented in GROMACS 4.5 using an acceptor--donor--H cutoff angle
of 300 and a donor-acceptor cutoff distance of 3.5 A. Ramachandran angles were likewise
extracted using the GROMACS gchi utility for each trajectory.
in the peptide, and the second digit corresponds to the number of hydrogen bonds the proline CO accepts
from water (Figure 3 and 4). For this chapter a peptide-peptide hydrogen bond is defined as having an
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Opeptide---Npeptie-Dpeptide angle 5 30' and a Opeptide---Npeptide distance : 3.5A and a peptide-water hydrogen
bond is defined as having an Opeptie--Owater-Dwater angle 5 300 and a 0 peptide---Owater distance < 3.5A.
Dynamic FTIR and 2D IR spectra were calculated for each hydrogen-bond bin. This was performed by
ensemble averaging only the parts of a MD trajectory belonging to a particular bin. To do this a trajectory
was checked for whether a structure corresponding to a particular bin was found in the middle of the next
5 ps of the simulation. If it was found the spectrum was calculated. As expected, calculations of FTIR
spectra show that the lowest frequency amide I' peak red-shifts with increasing number of hydrogen
bonds to the proline (Figures 5 and 6). The simulated FTIR spectra of Gly in Figure 5
0/0 1/0 2/0
'to ~~ 0 0 0 0
(O(C-1) O(CM1) O(cm-1)
Figure 5. (Top) Visualization of representative turn structure in the 0/0, 1/0 and 2/0 bins.
(Bottom) Simulated FTIR spectra for the Gly peptide in the 0/0, 1/0 and 2/0 bins.
shows that: 1) the proline resonance is not resolved for the 0/0 bin, which consists of disordered turns or
condensed states that do not accommodate hydrogen bonds, 2) the proline resonance has a weakly red
shifted tail and a small increase in intensity in the 1/0 bin, which predominantly consists of type II p-turns
(i-*i+3 hydrogen bond) or bulged turns (i--i+4 hydrogen bond), 3) the proline resonance has both a
large red-shift and increase in intensity in the 2/0 bin, which predominantly consists of an irregular p turn
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with dual hydrogen bonds (i.-*i+3 and i-+i+4) corresponding to D/W angles for the VPGV sequence of i:
-79*/1510, i+1: -59*/127 0 ,i+2: 118*/-290, and i+3: -128*/-30*. These simulated proline
-2/0
-0/2
0/0
Gly -Exp
Ala
Val
000 '0 '0 0PO 0 00 00
fo(cm 1)
Figure 6. Comparison of experimental and simulated FTIR spectra for the Gly,
Ala and Val peptides in the six hydrogen bond bins. Note the non-zero offset of
the blue side of the spectrum is the result of a broad -COOD stretching vibration
centered at 1722 cm-1.
peak shifts were also observed for the lowest frequency amide I' peak in the experimental spectra. For
example a high population of the irregular P turn is observed in the experimental spectra for the Val
peptide which has a proline peak with a red-shift relative to the band maximum of (Wmax - op) = 31 cm~1.
This model reproduces the features in the experimental spectra with the exception of the antiparallel p
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Figure 7. Comparison of the experimental data (lop row) to the six simulated surfaces
generated for each peptide.
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sheet's parallel mode. The parallel mode was found to be more intense in the experimental data where it
is observed as a subtle shoulder on the blue side of the amide I' band (Figure 1). Since the proline red
shift is the primary observable used to predict structure in this study a small difference in intensity on the
blue side of the spectra does not diminish the value of the model.
To assign the hydrogen bond population of each peptide, 2D IR spectra were simulated for the six
hydrogen bond bins (Figure 7). The non-linear intensity dependence in conjunction with the additional
frequency dimension of a 2D IR spectrum reveals information on hydrogen bond composition not seen in
FTIR spectra. The salient features common to all of the peptides simulated are summarized in Figure 8.
Now better resolved, the red-shift of the proline resonance provides a count of the number of
1680- 10 1/0 2/0
S1660(a) (1640
31620
1600
1680- 0/2 2/0
1660-
(b) -640
1 620-
1600
0 10 O O15 O O O
o 1 (cm-1) 01 (cm-1 ) o1 (cm- 1)
Figure 8. (a) Simulated 2D IR spectra of the Val peptide as a function of peptide-peptide
hydrogen bond number. (b) Simulated 2D IR spectra of the Val peptide as a function of
peptide-peptide vs. peptide-water hydrogen bonds.
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Figure 9. Average frequency of the simulated proline peak maximum for the 0/0, 1/0 and
2/0 bins. The linear fit to this data produced an equation relating the frequency of the
proline peak and the number of peptide-to-proline hydrogen bonds: op(cm-1) -
13.8-npr + 1642.
1645-
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1605 0 1 2
Total number of peptide-peptide and
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Figure 10. Average frequency of the simulated proline peak maximum for all six bins
plotted as a function of the total number of peptide and water hydrogen bonds to proline.
The linear fit to this data produced an equation relating the frequency of the proline peak
and the total number of hydrogen bonds to proline: op(cm-) ~ - 12.6-nm + 1642.
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hydrogen bonds to proline (Figure 8a). Fitting the simulated lowest mode peak frequency as a function of
the total number of hydrogen bonds to proline (nT) for all six states gives the equation to,(cm-') -
12.6-nT + 1642. (Figure 9 and 10)
In addition, spectral modeling of the six bins has shown that for these peptides the proline peak is
more intense when proline is hydrogen bonded to a peptide amide unit than when proline is hydrogen
bonded to water. This effect is amplified by the non-linear intensity dependence of a 2D IR spectrum,
thereby providing a method of distinguishing whether proline's hydrogen bonds are donated by peptide
groups or water. Although precise lineshapes remain a challenge to simulate, features such as the
168 Gly Ala Val
s'166
Exp i6
£162
160
1/0:13% 2/0: 1% 2/0:24%
1680- 0/1:87% 1/1:22% 1/0: 58%
~ 166 0/2:29
Fit %a1620 S
160
o1(cm-1) o,(cm-1) o1 (cm-1)
Figure 11. (Top row) Experimental 2DIR data, (Bottom row) - Fitted spectra, generated
by fitting the experimental data over the frequency range 1575 to 1650 cm~ with the
simulated spectra for all six peptide bins using a genetic algorithm containing a least
squares fitness function and no additional constraints. Since the amide I' band maximum
is located at -1645cm-I this fit range allowed for fitting both the proline peak shift and its
intensity relative to the main amide band. Listed to the right of each surface is the
population of individual HB bin's predicted from the fitting routine. Contours for all 2D
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IR surfaces presented in this paper are plotted from -1.0 to 1.0 in equally spaced steps of
0.08.
relative intensity or frequency splitting of the proline and main amide band are characteristic enough to
uniquely distinguish those states with varying peptide-to-proline hydrogen bonded configurations. These
conformers can be grouped as irregular i-+i+3 and i-+i+4 turns (2/0 or 2 hydrogen bond (HB) turn),
i-+i+3 p-turns or i-+i+4 bulged turns (1/0 and 1/1, or 1HB turn), compact disordered states (0/0 and 0/1),
and the 0/2 states which primarily consists of extended conformers.
In order to assign an approximate hydrogen bond composition for each peptide the experimental
2D IR surfaces were fit for frequencies <1650 cm 1 with the simulated 2D IR spectra for all of the peptide
bins using a genetic algorithm containing a least squares fitness function and no additional constraints
(Figure 11). The Gly peptide was found to contain approximately 15% 1HB turns, and <1% 2HB turns.
The remainder consists of highly disordered peptide configurations. The Ala peptide was found to contain
approximately 70% 1HB turns, <10% 2HB turns, and the remainder in disordered condensed or extended
states. This is consistent with a high population of type IlI turns and bulged turns for the folded state of
the Ala peptide. Finally, the Val peptide was found to contain approximately 60% 1 RB turns and -25%
2HB turns, which is consistent with a high population of type II [3turns, bulged turns and irregular p
turns. Although these populations are imprecise they provide a significant improvement over MD based
predictions (Figure 12 and Table 1).
Bin Population (%)
200 ns 27.5 ns Fit
2/0 5.9 4.9 ~25
1/1 3.2 1.3 <5
1/0 12.7 11.5 50-60
0/0 19.6 19.1 <5
0/1 47.1 49.9 <5
0/2 11.1 12.9 ~20
Table 1. Bin populations calculated from a 200 ns MD trajectory, 27.5 ns MD trajectory,
and the 2D IR experimental surface fitting for the Val peptide.
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Figure 12. Comparison of the experimental spectrum for the Val peptide to simulated
spectra using the bin populations generated for the fitting of the experimental data and
populations calculated from a 200 ns MD trajectory.
4.4 Conclusions
The 2D IR data shows a systematic change in turn conformational preference as a function of
point mutation. Here as the size of the X amino acid's side chain decreases the number of proline
hydrogen bonds to the peptide decreases and the number of proline hydrogen bonds to water increases.
This indicates that the preference for the X-Pro-Gly sequence to form a p-turn increases in the order Gly
< Ala < Val. The observed stabilization of the X-Pro-Gly turn may arise from a number of factors,
including steric clashes between the side chain of the point mutation and proline's pyrrolidine ring and
hydrophobic clustering of the X and Val side chains.
The Val peptide's irregular 2/0 p-turn was found to result from the formation of dual hydrogen
bonds between proline and the N-H moieties of two sequential amino acids following the PG loop. A
search of 75587 PDB entries using the p/yV for the Val peptides VPGV segment in a 2/0 turn, found 158
protein segments containing a 4 amino acid sequence with these p/ angles using a search tolerance of
300.25 Of these sequences 21% had a proline in the i position, 21% had a proline in the i+ position, and
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87% have a glycine in the i+2 position. Clearly, the Gly residue plays a crucial role in accommodating
the tight 2/0 turn conformation in this sequence. Interestingly, a similar conformation was previously
observed by X-ray diffraction in the cyclic peptide (APGVGV) 2 where the cyclic constraint generates a
closed turn.2 6
To summarize, this chapter has presented three findings which should prove useful in future
studies of structure in proline-containing systems. First, the X point mutation provides a robust means of
tuning the compactness or stability of turns in engineered proteins and biopolymers. Second, the
frequency shift of the lowest frequency amide I' vibration in the FTIR spectrum can be employed as a
measure of the number of hydrogen bonds to proline. This finding is particularly interesting because it
provides a simple method for interrogating protein structure in proline rich tissue samples such as elastin
and collagen matrices that are not readily addressed by other methods. Third, through the use of 2D IR it
is possible to assign the hydrogen bond composition of these turns. With further refinement of the
modeling methods, it will be possible to quantitatively assign the population of the different
conformations in the equilibrium structural ensemble of each peptide from the 2D IR spectrum. This
analysis will thereby provide a new approach for characterizing conformational states in intrinsically
disordered proteins. In addition, it can be used in the future to benchmark the accuracy of commonly used
force fields to describe structural and dynamical properties of small peptides.
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Chapter 5
Isotope-Edited 2D IR Study of the GVGVPGVG
Peptide
5.1 Introduction
Intrinsically disordered sequences (IDSs) are amino acid sequences that do not form a
stable secondary or tertiary structure in solution under physiological conditions. These IDSs
instead are found to exist as a heterogeneous ensemble of conformations that may interconvert
on timescales from picoseconds to microseconds. Once considered rare and ineffectual, over the
past decade it has become clear that IDSs play a crucial role in biological systems.'~3
Bioinformatics base predictions estimate that IDSs are common in proteins responsible for
physiologic and pathologic regulation, recognition, and signaling.4'5 Intrinsically disordered
regions (IDRs) and intrinsically disordered proteins (IDPs) are predicted to be heavily expressed
in numerous diseases including cancer, diabetes, Parkinson's, Alzheimer's and cardiovascular
4-7disease.4- As a result developing the means to characterize the heterogeneous ensemble of an
IDS is a required step for the advancement of human health and disease prevention.
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Detailed structural characterization of samples containing a high percentage of IDSs is
difficult using methods such as x-ray crystallography, fluorescence, NMR, ESR and SAXS." 11
Never the less these techniques have been employed to gain valuable insight into the properties
of IDSs. For example, IDSs of> 30 amino acids and 10 to 29 amino acids are observed in ~10%
and -40%, respectively, of the x-ray crystal structures in the PDB 1 The recent identification of
patterns in these sequences, through the use of bioinformatics base methods, has aided in the
creation of algorithms for predicting IDSs. In solution NMR experiments, the deviation of
chemical shifts and NOE values from there expected random coil values have been used to detect
transient secondary structure. 12-14 Never the less, none of the techniques currently used to study
IDSs have a time resolution that is faster than the life time of a transient conformation in a highly
disordered sequence. As a result averaged measurements are used for structure determination
thereby diminishing the ability to resolve structural heterogeneity in the ensemble. One
promising technique for studying IDSs is isotope-edited two-dimensional infrared spectroscopy
(2D IR) because of its ability to measure protein secondary structure with picosecond time
resolution. 15-2 1 Since the conformations of an IDS exchange on a longer time scale than the 5-6
ps required for the 2D IR measurement, it is possible to use 2D IR to distinguish between
transient structures in a heterogeneous ensemble.
In this chapter we use 2D IR spectroscopy in conjunction with spectral modeling from
molecular dynamics simulations to identify the dominant structures that exist in the equilibrium
ensemble of an elastin-like peptide. Elastin is a ubiquitous IDP found in the extracellular matrix
of animal connective tissue. This protein contributes to organ morphology, provides the
restoring force for bodily tissues after mechanical deformation, and is a signaling protein in the
regulation of smooth muscle cell activity during morphogenesis and disease. 22-32 Numerous
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models have been proposed for the structure of the elastin protein including the
phenomenological single phase classical rubber,,33 34 and liquid drop models,35 as well as the
structure based oiled coil,36 p-spiral,37 cis-trans isomerization,38 and three phase models.3 9
Though since the structure of elastin remains unassigned, the molecular mechanism of elastin's
elasticity and signaling are still open to debate. This dearth of information on elastin's molecular
structure results from both the fibrous structure of the natural protein and the high mobility of its
peptide backbone. The mature elastin fiber is composed of a protein microfibril which is bound
to and enveloped by a cross-linked network of the precursor protein tropoelastin where the
microfibril is believed to act as a scaffold for the deposition and alignment of tropoelastin. 40'41
The mature elastin fiber cannot be crystalized and as a result is an unsuitable sample for X-ray
diffraction. The fiber is also highly insoluble in water and as a result is an unsuitable sample for
solution NMR. In recent year's solid state NMR experiments have been performed providing
insight into the structure of dry and semi-hydrated elastin fibers.42,43 Never the less a solid state
NMR based structure of elastin under more native hydrated conditions has remained elusive due
to the increase in mobility of elastins peptide chains upon addition of water. As a result many
researchers have studied the water soluble tropoelastin as well as peptides consisting of repeating
units of amino acid sequences found in the natural protein which are termed elastin-like peptides
(ELP). With the exception of small cyclic ELPs,44'4 5 these samples, like the mature elastin fiber,
cannot be crystalized and have fast conformational motions that are difficult to resolve with
NMR. Since 2D IR spectroscopy can provide structural information on fast time scales and can
interrogate non-crystalline samples it is an ideal tool for studying elastin.
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5.2 Background
For humans the native elastin protein is encoded by a single gene on chromosome 7.46
This gene codes for several domains, the two most common of which are hydrophobic and cross-
linking domains. The hydrophobic domains are alanine, glycine, leucine, isoleucine, proline, and
valine rich and are responsible for the elasticity of the protein. 36'47 The cross-linking domains are
either proline or alanine rich with a periodic incorporation of lysine residues for cross-linking to
neighboring elastin proteins.36' 4 7
Elastogenesis begins in the rough endoplasmic reticulum of fibroblasts, or smooth muscle
cells, which generate the soluble 760 residue -70 kDa elastin protein precursor tropoelastin. 48
During synthesis tropoelastin binds to a 67 kDa galactolectin elastin-binding protein (EBP)
which functions as a chaperon by preventing the thermodynamically preferred aggregation of
tropoelastin that occurs under physiological conditions.4 9 After secretion from the cell the EBP
interacts with galactosugars attached to the microfibril network in the extracellular space
triggering the release of tropoelastin. This free tropoelastin aligns itself with the scaffolding of
the local microfibril network and is then posttranslationally modified by lysyl oxidase. Lysyl
oxidase is a copper-dependent catalyst that converts lysine side chains to allysine residues which
are required for cross-linking.50 Next, allysine and lysine residues covalently bond to their
allysine and lysine counter parts on neighboring tropoelastins to form lysinonorleucine,
merodesmosine, desmosine and isodesmosine cross-links.5 1 52  This reaction irreversibly
incorporates the tropoelastin monomer into the elastin fiber. This incorporated monomer will
subsequently be cross-link to newly deposited tropoelastin proteins, repeating the cycle of
elastogenesis which ultimately ends in the generation of a complete elastin fiber.
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The elastin fiber has remarkable material properties whose absence causes numerous
pathologies. As a result elastin has been the subject of extensive study in the fields of medicine,
biology and materials science. Elastin networks are crucial to organ morphology and when they
are malformed as is the case in supravalvular aortic stenosis,24,29,31,32 elastoderma,5 3
atherosclerosis, 30,31 marfan syndrome, 54'5 5 and cutis laxa,2 8 it results in pronounced medical
complications and in some cases death. In the field of material science the novel properties of
elastin and its synthetic mimics have been exploited for use as particles for drug delivery, 56
transducers,5 7 separatory materials, 58-60 and as a scaffold for growing synthetic tissue.61
At low temperatures the elastin protein exists in an extended state, which upon heating
contracts and aggregates to form a coacervate phase.62-68  Elastin coacervation is a
thermodynamically reversible process in which tropoelastin monomers self-assemble to form a
semi-ordered 50-60% hydrated phase where the monomers align their lysine rich regions for
cross-linking. This counterintuitive structuring upon heating is known as an inverse temperature
transition (ITT).6 9 Elastin also forms a coacervate upon addition of salt or raising the pH.63 In
the case of human tropoelastin the optimal coacervation conditions are found at 37 0C, 150mM
NaCl and pH 7-8 which is similar to the physiologic conditions found in the human body. 63 In
its folded state above the ITT, elastin becomes a robust elastomeric material that can perform
repeated cycles of extension and contraction without rupture. For example elastin in human
lung parenchyma, which is under continuous dynamic stress, was found to have a mean life span
of 74 years.70 This resilience is due in part to its strength, capable of lifting weights that are
1000 times larger than the weight of the dry matrix.7 1
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5.3 Current models for elastin
Over the years many models have been proposed to explain the viscoelasticity of elastin.
In this section several of the more commonly referenced models will be discussed. Currently no
one model can be used to self-consistently explain the properties of elastin. None the less these
models in the aggregate provide clues as to the actual structure of the peptide.
The classical rubber model, proposed by Hoeve and Flory in 1974, is one of the earliest
models apply to explain elastin's viscoelasticity. For this work they performed calorimetric
force extension studies on an elastin sample immersed in mixtures of water, ethylene glycol, and
alcohol concluding that elastin behaves like a standard rubber. For a classical rubber the
restoring force results from the configurational entropy gain associated with transitioning from
an extended state where the polymer chains are aligned to a contracted state where the polymer
chains are randomly oriented. Since this mechanism is based on the ordering of the polymer
chains it applies to both dry rubbers and rubbers containing solvent molecules in the polymer
matrix. As a result this model fails to explain the elasticity of elastin since in the absence of
water elastin becomes brittle. 35 This also implies that interactions between water, which acts as a
plasticizer, and the peptide are at the heart of the mechanism governing elastin's elasticity. 72 An
alternate entropy driven mechanism could be given in which elastin transitions from a contracted
state where the hydration water is disorder to an extended state where a portion of the hydration
water forms ordered networks. Although not proposed in the work of Hoeve and Flory many
models have been created that incorporate the effects of waters configurational entropy and will
be discussed later in this section.
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In an early attempt to explain waters role in the proteins mechanism of elasticity the oiled
coil and liquid drop models were proposed building on the two-phase model of S. M.
Partridge.35,36,73,74  The liquid drop model, proposed in 1970 by Weis-Fogh and Anderson,
describes the elastin fiber as a two phase system consisting of a cross-linked network of protein
globules with water in the spaces in between (figure 1).35 In its contracted state these globules
take on a spherical shape thereby minimizing the water protein interface. Upon extension these
spheres become elongated generating a larger surface area and in turn bringing buried
hydrophobic side-chains that are at the interior of the globules to the surface. Since the solvation
A B
Figure 1. Structure of elastin proposed by Partridge in 1966, 7 as well as Weis-Fogh and
Anderson in 1970.35 They described the elastin fiber as a cross linked network of
collapsed peptide globules, represented by circles and ellipses, with water in the spaces in
between. Image (A) represents the extended state of the fiber and image (B) represents
the contracted relaxed state of the fiber. This figure was reproduced from the work of
Weis-Fogh and Anderson."
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of a hydrophobic group requires the generation of an ordered network of water to envelop it this
hydrophobic hydration creates the entropic driving force for the hydrophobic collapse of the
protein returning it to a contracted state.
- 0 lhsV vink
Figure 2. Proposed oiled coil model for elastin taken from the work of Gray, Sandberg,
and Foster.36 Here the elastin fiber consists of alternating segments of cross linking a-
helical regions and elastic oiled coils.
In contrast Gray, Sandberg, and Foster in 1973 proposed the oiled coil model based on
the discovery that sequences like PGVGV are found as repeating monomer units in an elastin
sample isolated from copper-deficient pig aortae. 36 The oiled coil model like the liquid drop
model also describes elastin as a two phase system where a network of cross-linked protein units
are suspended in water. The difference between these models is that the liquid drop model
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describes these protein units as globular whereas the oiled coil model describes them as fibrillar.
The distinction here is that these fibrillar units contain a defined secondary structure (figure 2).
According to the oiled coil model the peptide chain of the fibrillar unit forms a coil with broad
loops 12-15 A in diameter with Gly oriented towards the exterior of the coil and Pro, Val and
other hydrophobic side chains located in the interior of the coil. As a result the recoil force in
this model comes from breaking the peptides secondary structure where the primary site of
hydration upon extension is the proteins backbone as opposed to the side-chains as proposed in
the liquid drop model. Both the oiled coil model and the liquid drop model adequately explain
the thermodynamics of force extension and contraction of the polymer and the role that water
plays in generating elasticity. Never the less these models has been criticized based on the belief
that the fast conformational motions of the peptide back bone would prevent the globules or
fibers from remaining intact.7 5 These arguments often cite the NMR experiments of Torchia and
Piez that found that 80% of the backbone carbonyl carbons in a sample of calf ligamentum
nuchae had a rotational relaxation time of TR 40 ns.76
132
A.
B. p-turn E. 1-spiral F. twisted filament
0 G 
of $-spirals
C),aVa 
f5
C. D.
03
P 
CV - V4
H-1.8nm-H
Figure 3. The p-spiral structure of elastin proposed by Dan W. Urry and coworkers. (A)
Schematic representation of the poly(GVGVP) sequence demonstrating how the PG unit
creates periodic p-turns. (B) PG turn structure from the crystal structure of the cyclo-
(GVGVP) 3 peptide. (C and D) Helical representations of the poly(GVGVP) sequence
with and without the PG p-turns. (E) Stereo plot of the p-spiral structure. (F) Proposed
structure for the association of p-spirals to form twisted filaments drawn with a space-
filling united residue representation. This figure was reproduced from the work of Dan
W. Urry.2 3
An alternative to these models was proposed by Urry which described the structure of
the ELP (VPGVG)n as a p-spiral (figure 3) based in part on the NMR and x-ray crystal structure
for cyclo-(VPGVG) 3.37'44 '77-79 In this model upon heating the ELP transitions from an extended
state to a folded helical structure. The proposed helix has a pitch of 10 A for each successive
loop around the helical axis with no hydrogen bonds between successive loops. Each loop
consists of three VPGVG units with the PG in a p-turn conformation that is parallel to the helical
axis. Unlike the structures proposed for the oiled coil and liquid drop models the p-spiral has the
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hydrophobic segments of the peptide chain on its exterior surface and has large cavities on this
surface allowing water into the interior of the protein. This model is consistent with the findings
from CD and UV resonance Raman studies that upon folding the population of p-turns in the
sample increases. 79'80 This model also provides an explanation for the similarity between the
cyclo-(VPGVG)3 and linear ELP NMR, CD, and UV resonance Raman (UVRR) spectra.79-81
Never the less since the p-spiral structure lacks a hydrophobic core this model cannot account for
waters role in imparting elasticity. In addition the p-spiral model relies on the formation of a
structure with long range order which is unlikely given the high conformational entropy of
elastins peptide backbone. Finally MD simulations by Daggett and coworkers have shown that
an idealized p-spiral is not stable in water and upon heating collapses to form a compact
amorphous state with only short range order.75,82,83
Using CD and UVRR measurements the work of Asher and coworkers also showed
similarities between the spectrum for a linear peptide, GVG(VPGVG) 2VP, and the cyclo-
(VPGVG) 3. Unlike the work of Urry and coworkers though, they did not detect a pronounced
change in conformation for the linear peptide upon heating. Instead they found that the linear
peptide at 20 C has a high population of p-strands, and type III P-turns (Note: A type III p-turn
contains the torsion angle 9i+1 = -60*, xVi+i = -30*, 9i+2 = -60', %+2 = -30,)84'85 with only a small
increase in type II p-turns with heating to 60 C. This small increase in type II P-turns is in
contrast to the large increase that would be expected for the formation of a p-spiral for a longer
sequence.
Unlike the work of Asher and coworkers, other authors propose more substantial changes
in confirmation for small ELPs upon moving through the ITT. For example Reiersen et. al.
studied the temperature dependent conformational changes in a family of 15 peptides based on
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the sequence GVG(VPGVG)n where n = 1-5 using CD spectroscopy.86 They found that all
peptides studied had an ITT which upon heating is observed as a loss of random coil structure
and a gain of type-II p-turn structure which may be in equilibrium with multiple p-turn
conformations. In addition they found that the entropy and enthalpy change for the phase
transition was similar for all peptides and as a result proposed that the folding of elastin is non-
cooperative and that the VPGVG monomer was the fundamental unit of elasticity. Never the
less since this work was performed on peptides < 28 amino acids it does not conclusively
disprove the existence of a cooperative phase transition for larger peptides
Winter, Marx, and coworkers also proposed that the small GVGVPGVG (GVGn1)
peptide has an ITT. This proposal is based on CD, FTIR, differential scanning calorimetry,
pressure perturbation calorimetry, and MD simulations that show two state behavior for the
peptide.87-89 According to these studies the peptide is in an unfolded state at low temperatures,
10-30 0C, consisting of disordered structures and y-loops and a folded state at temperatures
above the ITT, 40-60 *C, consisting of s-strands and type 11 p-turns. From there MD simulations
they found that upon folding the peptide forms 2-3 peptide-peptide hydrogen bonds and loses
~20 water molecules that are found to solvate backbone hydrophilic groups at low temperatures.
In contrast to the liquid drop model they observe no change in the number of solvation waters
encapsulating the side-chains. Thus according to Winter, Marx, and coworkers back-bone
hydrogen bond contacts drive the phase transition not the waters of hydrophobic hydration. This
conclusion is in direct disagreement with the liquid drop model but to a small extent is consistent
with the p-spiral and oiled coil models which relay on secondary structure formation driving the
ITT. Never the less since these studies were performed on an eight amino acid peptide it is not
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conclusive proof that hydrophobic hydration does not drive the phase transition of longer ELP's
and the native protein.
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Figure 4. MD structures for the (VPGVG) 18 peptide at temperatures from 7 to 42 *C, 6
ns after starting from a p-spiral conformation. The peptides main chain is drawn in red
and side chain atoms in green. This image was reproduced from the work of Daggett and
coworkers.83
In opposition to the work of Winter, Marx, and coworkers, Daggett and coworkers
proposed a hydrophobic collapse model. This proposal was based on both equilibrium and force
extension MD simulations for the (VPGVG)18 peptide.5 ,82,83  In this description at low
temperatures the peptide exists in an extended state with 36% short range p-spiral structure,
existing on a 5 residue length scale, which upon heating decreases to 26% p-spiral structure as
the peptide undergoes a hydrophobic collapse (figure 4). This collapse is accompanied by a
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reduction in solvent accessible surface area for the hydrophobic side chains as well as an
increase in the population of P-strands, p-turns, and the formation of a hydrophobic core. As a
result, like the p-spiral, the model of Daggett and coworkers is consistent with the experimental
observation of p-turn formation above the ITT. Unlike the P-spiral model, the model of Daggett
and coworkers does contain a hydrophobic core and therefore is also consistent with
thermodynamics studies on the protein under force extension. In this respect the model of
Daggett and coworkers is consistent with the liquid drop model since they both claim that
hydrophobic hydration plays a role in the proteins elasticity. But unlike the oiled coil and liquid
drop models the globules described by Daggett and coworkers are loose with the protein moving
through large amplitude cycles of extension and contraction with the backbone remaining
solvated even in the collapsed state. As a result this hydrophobic globule model also does not
contradict the finding that elastin has highly mobile chains in its collapsed state. One limitation
to the model of Daggett and coworkers is that it is based on simulations initiated from a p-spiral
structure. As a result given the short time scale of their simulations, < 100 ns in total, the
conformational ensemble may be biased towards a hire population of p-spiral like structures.
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Figure 5. Depiction of the three phase model proposed by Debelle et. al. In the lower
portion of the image is a cross linked (crosses) network of globular tropoelastin proteins
(circles) with bulk water (B) in the interstitial space. Above is a representation of the
structure with in a single tropoelastin globule. Here a-helical cross linking domains are
at the surface of the globule with a semi ordered peptide rich in p turns and strands with
hydration water molecules solvating these structures. This image is reproduced from the
work of Debelle et. al.39
Using a combination of sequence analysis, FTIR, NIR FT-Raman and CD spectroscopy
on natural elastin samples, Debelle et. al. proposed a modified version of the liquid drop model
of Weis-Fogh and Anderson.3',90-92 According to Debelle et. al., water swollen elastin is a three
phase system consisting of 1) peptide chains made up of both hydrophobic and cross-linking
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amino acid sequences, 2) hydration water which is tightly bound to the surface of the peptide,
and 3) bulk water that resides in the interstitial space between the peptide globules (figure 5). By
separating the water into two populations this model stresses the role of changes in waters
conformational entropy in generating the polymers elasticity. In this description in its relaxed
state the peptide chains are predominantly in unordered conformations with the bulk solvent
water interacting strongly with hydration water thereby preventing the hydration water from
hindering the mobility of the peptide chain. Upon stretching the conformational equilibrium
shifts towards ordered chains with possible formation of p-sheet structure. Simultaneously the
bulk water is expelled from the interstitial spaces between the globules which reduces the
number of interactions between bulk and hydration waters thereby allowing the hydration water
to restrain the peptide chains. This combination of structured restraining water and secondary
structure formation generates a large drop in entropy for the fiber. Upon removing this
elongation force elastin regains this entropy by recoiling according to a classical mechanism of
elasticity. This model is appealing because it accounts for the role of both water and peptide
conformational entropy. Never the less given the complexity of the sample used in their
experiments there results cannot definitively confirm this model.
Finally an alternative to the models presented above was proposed by Valiaev et. al. who
observed a temperature independent extensional transition in the single molecule force-extension
measurements of SKGPG(VPGXG) 180 where X can be Gly, Ala, or Val with the substitution
ratio 3:2:5. This work showed that there is a transition at 200 to 260 pN in the force extension
curves for the ELP which closely resembles extension measurements for poly(1-proline). Based
on this observation the authors proposed a cis-trans isomerization mechanism for elastin.
Though since the extensional transition in this study is temperature independent it does not
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explain the finding that tropoelastin's elasticity increases substantially upon heating past the
phase transition.8 As a result the transition measured by Valiaev et. al. could be separate from
the mechanism that imparts elasticity to the protein in vivo. An alternate explanation of the
findings of Valiaev et. al. is that the observed transition occurs at extension forces that are
beyond what is experienced by the natural fiber during regular physiologic function.
In spite of the disagreements in secondary structure assignments the studies listed above
and many other show that linear and cyclic monomer, oligomer, and polymer of ELP sequences
display similar spectroscopic features. 2 3 ,37,44,45,79,80,86,87,93-97 As a consequence a thorough
assignment of the vibrational spectrum of a model ELP can provide insight into the structure of
the family of elastin proteins. The elasticity of elastin is generally assumed to originate from
the conserved amino acid sequence PGV, PGGV, PVGG, PGVGV, PGVGVA, and
36,98PGFGVGAGV. The most common of these sequences both in the natural fiber and in
spectroscopic studies of elastin is PGVGV. As a result the GVGnl peptide was chosen for study
with 2D IR and FTIR.
In chapter 4 it was established, based on an experimental and theoretical study of the
proline amide I' vibration, that the GVGnl peptide contains a high population of closed turn
structures. This investigation is continued here with a study of isotope labeled analogs of the
GVGnl peptide. By implementing the labeling strategies out lined for the characterization of
TZ2 in chapter 3 it was possible to refine the description of the peptide turn. Next the effects of
salt concentration and temperature on turn conformation will be presented. Finally the effect of
peptide length on the turn conformation is explored.
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5.4 Experimental Overview
The library of 13CO and 13 CI80 isotopologues synthesized for this work are shown in
figure 6. This library includes the unlabeled or "wild type" (WT) peptide along with 5 single
labeled peptides and 3 multiply labeled peptides. The name assigned to each amide site listed
from the N to the C terminus is G3t, V4 , G5t, VI, P2, G3, and V4.
Figure 6. Library of peptides used for assigning GVGnl structure. Boxes indicate the
location of isotope labeled amide sites. All labeled amide sites were labeled with lC 80
except for the G3 site in VlG3V4 which was labeled with 13 C160 for increased peak
resolution. The monomer unit VPGVG is drawn in black in the WT structure with amide
sites numbered to demonstrate the naming convention used in this work.
This naming scheme reflects the fact that VPGVG is a monomer unit in the elastin biopolymer.
As a result the N terminal sequence G3tV4tG5t is numbered in accordance with their position in
the previous monomer unit which is distinguished with a t. It should also be noted that this
scheme assigns the name of an amide unit based on the amino acid to its N terminus. For
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example an isotope label on the amide unit between G3 and V4 is referred to here as the G3
label.
Five single 13 C 8 labeled peptides were synthesized, the turn labels V1, G3 and V4, the
mid-strand label G5t and the N-terminal label G3t. As discussed in chapter 3 isotope labeling
decouples the vibrations of an amide site from those of its neighbors providing a local probe of
peptides structure. By studying the line-shape of the labeled peak it is possible to gain local
information on hydrogen bonding, structural heterogeneity and the rate at which these
heterogeneous environments interconvert. In addition evaluating the frequency dependent
changes in the main amide I' band an cross peaks generated upon labeling provides clues as to
the sites contribution to the secondary structure of the peptide.
The dual 13C180 labels G5tG3 and VIV4 and the triple label V1G3V4, with "C"8 O on
the VI and V4 sites and 13CO on the G3 site, were synthesized for measuring peptide secondary
structure in analogy to the TT label in chapter 3. In the case of TZ2 the coupling of the T3 and
Ti0 isotope labels across a semi-ordered unit of p-sheet structure generated a measurable shift in
the site frequency of the TT peak relative to the single label peak for the T10 peptide. The same
approach was taken here for the multiply labeled peptides by comparing the FTIR and 2DIR
spectrum for each multiple label to their corresponding single label analogs. Since the labels in
the G5tG3, VIV4 and VIG3V4 peptides are located at positions around the turn they are capable
of reporting on changes to the turns structure.
These labels are first presented in the section below at 10 C to provide a description of
the average structure of the peptide. Next temperature and salt dependent data will be presented
to demonstrate the changes that occur to the structure of the turn as the peptide is driven through
142
the ITT. Finally data for GVG(VPGVG)n where n = 1-6 and (GVGVP) 251 will be presented to
determine if the length of the peptide effects the turn conformation.
5.5 Experimental Methods
All peptides presented in this chapter with the exception of the (GVGVP) 25 i were
prepared using Fmoc-based solid phase peptide synthesis as described in chapter 2 using Gly-
Wang resin. Peptides synthesized using SPPS were purified by reverse phase HPLC using a
two-phase buffer gradient: (buffer A) 0.1% TFA in H2 0 and (buffer B) 80% acetonitrile, 0.085%
TFA in H20 and were desalted where indicated below. These peptides were subsequently 3x
dissolved in an HCl solution and lyophilized to remove TFA from the sample.99 100 The
recombinantly expressed (GVGVP) 251 was obtained from Dan W. Urry of Bioelastics Research
Ltd. and was used without further purification. Isotope labeled Fmoc amino acids were
purchased as 99% enriched 1-13C labels from Cambridge Isotope Laboratories. To create the
13C18 0 labels the carboxyl oxygen's of the 1- 3 C labeled Fmoc amino acids were then labeled
with 180 to ~97% isotope enrichment via acid hydrolysis in H2 180 purchased from Isoflex USA.
Samples for 2D IR and FTIR experiments were first dissolved in D2 0 and lyophilized in
order to remove H2 0 and exchange acidic protons in the sample for deuterium. The dry
deuterated product was then dissolved in pH = 1.0 DCl in D20 with 0, 75 or 150 mmole of
KD2PO 4 or pH = 1.0 DCl in D2 0 with 150 mmole of the mixture K2DPO4 and KD2 PO 4 in a 1:1
molar ratio. A sample of the 150 mmols solution of the K2DPO4 and KD2PO4 mixture was
analyzed by Northeast Environmental Laboratory, Inc. (Danvers, MA) which measured the
concentration of the potassium, chloride and orthophosphate ions to be K+ = 207 mmole, Cl~ =
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256 mmole, and P04 = 130 mmole. Peptide samples were prepared at concentrations from 15.0
to 50.0 mg/ml with no spectral changes observed over this range. Next samples were placed
between two 1mm thick CaF2 windows with a 50 pm Teflon spacer generating a ~25 jtL sample
volume. The sample was then mounted in a temperature controlled brass sample holder. FTIR
data was collected with a Nicolet 380 FTIR spectrometer in a dry air purged environment at a
resolution of 2.0 cm'. 2D IR spectra were collected in a dry air purged environment using 100
fs broad band mid-infrared pulses with a T1 evolution time that was scanned to 3.1 ps for
rephasing spectra and 2.5 ps for non-rephasing spectra. Data was collected in both ZZZZ and
ZZYY polarization geometries at a variety of waiting times ranging from T2 = 0.0 to 1.5 ps as
will be indicated below.
5.6 FTIR and 2D IR spectra
The FTIR spectra for the desalted GVGn1 isotopologues at 10 C in pH = 1.0 DCl in D20
with 150 mmole of KD 2PO4:K2DPO4 (1:1 by mol) are presented in figure 7. The amide I'
spectrum of GVGn1 contains several notable peak features which will be briefly reviewed in this
section. The peak at o = 1614 cm 4 , in the FTIR spectra of WT, G3t, G5t, G3, V4 and G5tG3, is
attributed to the amide I' vibration of proline. The peaks at o = 1640 and 1670 cm-1 are assigned
to the vi and vj antiparallel p-sheet modes.o101" 2 The peak at o = 1660 cm' is assigned to
random coil vibrations since GVGn1 is an eight residue peptide with a central proline and is
therefore unable to from an a-helix. Finally, the non-zero offset on the blue side of the spectrum
is the result of the COOD stretching mode that is centered at ~1725 cm 4 . Isotope labeled peaks
appear on the red side of the spectrum with peak maxima at frequencies ranging from 1554.4 cm-
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1 for the "C" 8O labeled V1 site in the VI peptide to 1610.3 cm~1 for the 13CO labeled G3 site in
the V1G3V4 peptide. The combination of the "Co, 13C 8 0 , and proline red shifts of 41, 60, and
27 cm'1 respectively can provide a high degree of site specific resolution in a single spectra as
evidenced by the V1G3V4 peptide.
V1G3V4
V1V4 o
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Figure 7. FTIR spectrum for the GVGnl peptide library collected at 10 *C on desalted
peptides in pH = 1.0 DCl in D20 with 150 mmol of KD 2PO4:K2DPO4 (1:1). The green
and circle are placed at 1635 and 1675 cm- to indicate the location of the p-sheet vi and
vIl modes respectively.
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The 2D IR spectra for the desalted GVGnl isotopologues at 10 C with a waiting time of
T2 = 150 fs in pH = 1.0 DCl in D20 with 150 mmole of KD2PO4 :K2DPO4 (1:1) are presented in
figure 8. Due to the non-linear scaling of intensity in a 2D IR surface peaks are better resolved
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Figure 8. 2DIR spectrum for the library of GVGnl peptides used for assigning the
peptides structure. Spectrum were collected in ZZYY polarization at 10 0C and T2 = 150
fs on desalted peptides in pH = 1.0 DCl in D20 with 150 mmol of KD2PO4 :K2DPO4 (1:1).
Note that due to the desalting of the peptides these 150 mmol spectrum contain line-
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shapes similar to spectrum collected for peptides prepared without a desalting step and
dissolved in pH = 1.0 DC1 in D20 with no additional salt added.
than in the FTIR spectrum making the identification of peak features from a 2D IR surface a
robust metric for characterization. With the exception of G3t the 2D IR surfaces for all of the
peptides contain well resolved isotope peaks. As a result these data sets can be easily fit with
Gaussian peaks and interpreted using basic line-shape metrics such as center frequency ((o), on-
diagonal FWHM (A), off-diagonal FWHM (F), peak rotation and ellipticity (0 = (A2 - F2)/(A 2 +
F2)). Fitting the 2DIR surfaces gave peak frequencies of G5t: o= 1582.0 cm~1, VI: o = 1554.4
and 1572.2 cm-1, G3: (o = 1581.0 cm~1, and V4: (o = 1584.1 cm-1. In the case of the G3t peptide
it was not possible to extract the isotope peak frequency from the 2D IR spectrum because its
resonance is nearly degenerate with that of unlabeled proline. As a result FTIR difference
spectra were used to assign the isotope peak frequency giving an isotope peak of G3t: 0 =
1604.4 cm 1 (figure 9). Values for (o, A, F, and E are presented for all labeled sites in table 1.
o A F E
G3t 1604.4
G5? 1582.0 25.5 9.6 0.75
V1 (2/0) 1554.4 19.3 9.3 0.62
VI (1/0) 1572.2 16.3 10.0 0.46
G3 1581.0 34.6 10.4 0.84
V4 1584.1 24.4 7.6 0.82
Table 1. Center frequency (o), on diagonal FWHM (A), off diagonal FWHIM (F), and
ellipticity (E) for the isotope labeled sites of GVGn1. The values for (o, A, and F are
presented here in cm-1 and the value for the ellipticity is given by E = (A2 - F2 )/(A 2 - F2).
Peak metrics for all compounds with the exception of G3t were measured by fitting their
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2D IR spectra. Since the G3t isotope peak is partially overlapped in frequency with the
proline resonance it was not possible to accurately fit its 2D IR surface. As a result the
value for o was measured from the [G3t - WT] FTIR difference spectrum presented in
figure 9.
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Figure 9: [(Isotope Label) - WT] FTIR difference spectrum for the GVGn1 peptide
library collected at 10 *C on desalted peptides in pH = 1.0 DCl in D20 with 150 mmol of
KD 2PO4.
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5.7.1 Single Site analysis: V1
Peak frequency values provide insight into the local environment surrounding each
labeled site. In chapter 4 it was established, based on the peak frequency of the proline
resonance, that the GVGnl peptide contains a high population of 1/0 and 2/0 hydrogen bond
turns. This assertion is confirmed here by the presence of an asymmetric VI peak line-shape
(figure 10).
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Figure 10. Experimental V1 FTIR and ZZYY 2DIR spectrum collected at 10 'C on a
desalted peptide at T2 = 150 fs in pH = 1.0 DCl in D20 with 150 mmol of KD2PO4. The
FTIR spectrum was fit with 2 Gaussian peaks giving populations for the 2/0 and 1/0 turns
of 82% and 18%. In the upper right hand corner of the figure is a schematic
representation of the GVGnl peptide in a 2/0 turn with hydrogen bonds depicted as red
lines.
The asymmetric peak results from the over-lap of the 1/0 and 2/0 peaks at 1572.2 and 1555.4 cm-
1 respectively. The frequency difference of A = 17.8 cm-1 observed here is more similar to the
16cm-1 red shift per hydrogen bond found for the K8 label of TZ2 in chapter 3 then the 13.8 cm'
red shift per hydrogen bond found for the proline site in chapter 4. Based on the fitting of the
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2DIR spectrum the VI peak was found to have an A = 19.3 cm', F = 9.3 cm , and E = 0.62 for
the 2/0 peak and A = 16.3 cm', F = 9.9 cm', and E = 0.46 for the 1/0 peak. We find that the 2/0
structure contains a more heterogeneous distribution of local environments based on the 3 cm'
larger A. In addition this data shows that the ensemble of 2/0 turns is likely to exchange less
rapidly than the 1/0 ensemble based on the 2/0 peak having a 1.2 cm- smaller F and a 35%
increase in ellipticity relative to the 1/0 peak. A fitting to the VI FTIR isotope peak was used to
assign the relative population of the 1/0 and 2/0 turn giving 18% and 82% respectively. These
values are not in agreement with the results given in chapter 4 where the populations for the 1/0
and 2/0 turns were reported to be 55-60% and ~25% respectively. Never the less both
predictions show a high population of a closed turn. In contrast the MD simulations predict an
open turn with an 11.5% and 4.9-5.9% population for the 1/0 and 2/0 turn respectively.10 2 As
demonstrated in chapter 4 only peptide conformations with a closed turn reproduce the
pronounced proline peak shift in the GVGnl spectrum. As a result the values presented here and
in chapter 4, which predict a high population of a closed turn, are an improvement over MD
based results. These discrepancies also demonstrate the value of fully isolating peak features
through the use of isotope labeling where here the combination of the proline and l3C180 red-
shift changes the VI site frequency by Ao = -87 cm-.
The 2D IR data presented above was collected at a waiting time of U2 = 150 fs which is
small relative to the time scale of molecular motion. The result is a 2D IR surface that presents a
nearly static picture of the conformational ensemble. By studying the isotope labeled peaks as a
function of waiting time it is possible to track the configurational changes that occur for this
ensemble providing insight into the molecular dynamics of the peptide.10 3 As a function of
waiting time these isolated peaks transition from being on diagonally elongated to symmetric as
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the structure of the local environment and in turn the sites amide I' transition frequency evolves.
Encoded in these waiting time dependent spectral changes is information on local solvent
exposure, conformational flexibility, and chemical exchange. As described above the value of A
for an isotope peak is the result of the frequency for that transition being modulated by the
distribution of heterogeneous local environments that exist for that labeled amide site in the
ensemble. As a function of waiting time transitions that were initially at a frequency of ui
evolve to a new frequency o3 due to changes in the local environment, resulting in the
generation of two off diagonal peaks at (o ,(03) and (o3, oi). In the case of a rearrangement of
the local solvent environment or a transient conformational fluctuation of the peptide these cross
peaks generate a symmetric line shape with a rotation of the tilt of the on diagonal peak
maximum. In the case of chemical exchange these cross peaks can generate a distinct feature in
the off diagonal region of the spectrum.
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Figure 11: Waiting time 2DIR data for non-desalted VI and N-Acetyl-Pro-COOD
collected in ZZZZ polarization at 10 'C in pH = 1.0 DC in D20 with no additional salt
added. The black lines in the figure are the result of fitting the fundamental peak
maximum.
A comparison of the 2D IR waiting time spectrum for VI and N-Acetyl-Proline-COOD
provides further proof of the coexistence of a 1/0 and 2/0 turn in the equilibrium ensemble of
GVGn1 (Figure 11). Figure 11 shows that when the proline amide unit is not incorporated into a
peptide, as is the case for N-Acetyl-Proline-COOD, it contains a more symmetric line-shape that
becomes homogeneous with waiting time. The free proline peak has A = 27.6 cm~1 which is 69%
and 43% larger than the A for the 1/0 and 2/0 peaks respectively. This time scale and line width
is consistent with the presence of a water exposed amide unit since water exposure is known to
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generate broad line shapes and the observed relaxation time for this peak is similar to the
relaxation time of the OH stretch of HOD in D20.104 In contrast the VI peak does not rotate as a
function of waiting time. This lack of rotation combined with the peaks asymmetry is consistent
with the existence of two overlapping peaks. In this scenario both peaks do become
homogeneous with waiting time but since they are displaced along the diagonal axis it gives the
appearance of a single static inhomogeneously broadened peak.
5.7.2 Single Site analysis: G3 and V4
Ab initio calculations have shown that each hydrogen bond to the amide C=0 generates a
20 cm~ red-shift to the site frequency whereas each hydrogen bond to the amide N-H generates a
10 cm 4 red-shift.105 As a result the observation that both V4 and G3 have similar site energies
and peak rotation as a function of waiting time (figure 12) reinforces the proposed structure from
chapter 4 in which these sites on average have their N-H pointing in the same direction relative
to the peptide turn.
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Figure 12. Waiting time 2DIR data for non-desalted V4 and G3 collected in ZZZZ
polarization at 10 0C in pH = 1.0 DCl in D20 with no additional salt added. Each figure
has two perpendicular lines, one indicating the fit line for the fundamental peak
maximum and a perpendicular line in the anti-diagonal direction provided as a guide for
the eye.
This result is in contrast to the pattern of site energies and waiting time dynamics expected for a
standard hairpin with a type II p turn. For a standard hairpin these values are found to oscillate
along the peptide backbone as a result of the alternating orientation for amide units as observed
for TZ2 in the folded and frayed state (chapter 3 figure 11b).
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Despite these similarities differences do exist between the G3 and V4 sites. First the G3
site is found to have a A of 34.6 cm 4 which is 42% larger than the value of 24.4cm 1 found for
V4.
1550 1580 1610 1640 1670 1700
o(cm 1)
Figure 13. [(Isotope Label) - WT] FTIR difference spectrum for G3t (Red), G51 (Cyan),
G3 (Green), and V4 (Blue), collected at 10 C on desalted peptides in pH = 1.0 DCl in
D20 with 150 mmol of KD 2PO4.
Second the G3 and V4 sites display different loss features in the FTIR difference spectrum
(Figure 13). In figure 13 we see that for V4, intensity is primarily lost from the v±L and random
coil region of the spectrum which is consistent with a partially disordered site that participates in
a conformation containing a cross strand hydrogen bond. In contrast the G3 label displays loss
features across the amide I' spectrum potentially demonstrating a larger diversity of possible
solvent conformations for the G3 amide site. Both G3's broader loss spectrum and increased A
is consistent with a less constrained amide site do to the absence of steric hindrance created by a
side-chain moiety. Alternatively the broad loss feature could be the result of a strong coupling
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between the G3 site and its neighboring amide units. In the G3 FTIR difference spectrum there
is a local maximum at o = 1657.6 cm' and two local minimum at o = 1642.2 and 1669.3 cm'.
These values are similar to those for the random coil, vi, and vil peaks which have center
frequencies at 1660, 1630, and 1670 cm'. As a result this loss pattern is also consistent with a
strong coupling generating a large splitting between vi and vii with only a small contribution to
the random coil region. Finally the FTIR difference spectrum for G3 gains intensity whereas V4
loses intensity in the region from 1610 to 1620 cm' corresponding to the center of the proline
peak. The observed changes could result from a change in coupling with the G3 site gaining and
the V4 site losing its coupling to proline upon labeling. The G3 and V4 coupling to the VI site
will be revisited in section 5.8 using 2D IR spectrum for analysis.
5.7.3 Single Site analysis: G5t
G5t has a site frequency of 1582.0 cm 4 which is similar to the site frequency found for
G3 and V4. Based on this finding the G51 site is likely to on average have a solvent exposed
C=O and a N-H that is pointed towards the center of the peptide as was predicted for G3 and V4.
Though to confirm this assertion 2D IR waiting time measurements must first be carried out in
order to compare the rate of nodal rotation for the G5t isotope peak to the rates of G3 and V4 in
order to determine if there solvent environments have similar dynamics. In addition the G5t
FTIR loss feature is found to be similar to the G3 loss feature in that it contains a depletion in
intensity at vj, vii, and random coil frequencies. In contrast the G5 loss feature is broader and in
particular has smaller losses in the vi and vii regions compared to G3 which reflects a weaker
coupling of the G5t site with its neighboring amide units. Finally the G5t site is found to have a
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F = 9.6 cm-1 giving an ellipticity of E = 0.75. This value for E is 10.7% and 8.5% smaller than
the values measured for G3 and V4 respectively. The smaller ellipticity for G5t may indicate
that this site is more solvent exposed and since the V4 site is on average hydrogen bonded to VI,
as opposed to G5t as would be the case in a standard hairpin, the G5t site is not likely to
participate in peptide-peptide hydrogen bonds with sites in the turn.
5.7.4 Single Site analysis: G3t
Since the GVGnl peptide is enriched in glycine residues it displays a high degree of
conformational flexibility. As a result the N-terminus can bend in words towards the turn to
form peptide-peptide hydrogen bonds. For this reason the G3t label was synthesized to explore
the local environment around the N-terminus (Figure 14).
1640 1660
o(cm- 1)
Figure 14. FTIR spectrum for G3t (Red) and WT (Black) collected at 10 *C on desalted
peptides in pH = 1.0 DCl in D20 with 150 mmol of KD2PO4.
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We find that the G3t site energy is located at 1604.4 cm' which is blue-shifted by 21.4 cm'
relative to the average site frequency for the G5t, G3, and V4 sites. This indicates that the G3t
site has fewer hydrogen bonds or a different orientation of its amide C=O relative to the turn than
the G5t, G3, and V4 sites. In addition unlike the G5t, G3, and V4 sites the depletion in intensity
in the FTIR difference spectrum for G3t is concentrated in a frequency region to the blue of the
vi; with a small random coil component. Here the absence of a loss feature at the vi frequency
indicates that the G3t site on average does not participate in peptide-peptide hydrogen bonds.
These results for G3 are similar to the findings for the S1 label of TZ2 in chapter 3. In chapter 3
it was proposed that the S1 site has a high degree of conformational mobility, which would be
expected for a terminal amide group, but simultaneously has an amide C=O that is shielded from
the solvent generating a high frequency Sl peak. Given the high site frequency for G3t it is
likely that it also has an amide C=O that is shielded from the solvent. This assignment could be
explained by a conformation in which the N-terminus bends back towards the turn with its amide
C=O oriented towards the V1 and V4 hydrophobic side-chains. Though modeling of the G3t site
energy as a function of peptide conformation will be necessary to verify this assertion.
5.8 Multiple Site Analysis
In this section off diagonal peak structure generated from the formation of exitonic
vibrations will be explored to determine the strength of the peptide turn. To quantify the stability
of the turn the G5tG3, V1V4 and V1G3V4 peptides were synthesized. By spectroscopicly
isolating these combinations of amide sites it is possible to detect cross strand couplings that are
indicative of turn formation.
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This approach was utilized in chapter 3 in the form of the TT dual label to measure the
stability of the mid-strand peptide contacts. In this example the isotope peak of the TT double
label was found to be red-shifted relative to the T10 single label isotope peak due to cross strand
coupling between the local vibrations of T3 and T10. Since the G5t and G3 site energies are
nearly degenerate, A = 1.0 cm-1, these local vibrations can also mix to generate two new peaks
whose A frequency splitting and cross peak intensities are related to the coupling strength
G5t G5tG3 - G5t+ G3 - WT = = G3 -
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Figure 15. FTIR and 2DIR spectrum for G5t, G3, and G5tG3 collected at 10 0C on
desalted peptides in pH = 1.0 DCl in D20 with 150 mmol of KD 2PO4 . 2DIR spectrum
were collected in ZZYY polarization at T2 = 150 fs.
between the sites. For the conditions studied here no indications of cross strand coupling of the
G5t and G3 sites were detected as is demonstrated in figure 15. Visual inspection of the FTIR
and 2DIR data for G5t, G3 and G5tG3 peaks indicate that the dual labeled G5tG3 spectrum is
the result of a linear combination of the single labeled G5t and G3 spectrum. In addition the
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peak metrics for the G5tG3 peak, v max = 1581.7 cm', A = 29.7 cm-, F = 10.0 cm', and E = 0.79
are found to be similar to the average of the values for the G5t and G3 spectrum V max average
1581.5 cm 1 , A average = 30.1 cm-, F average = 10.0 cmI, and E average = 0.79.
Unlike the G5tG3 spectra the G3, VlV4, and VlG3V4 spectra do contain indications of
cross strand coupling. In figure 16 it can be seen that both the ViV4 FTIR and 2DIR spectra
contain features that are not the result of a linear combination of their corresponding single
labeled spectra. In the V1V4 FTIR spectra these differences are seen as an increase in peak
intensity for the V1 2/0 peak and an increase in intensity on the blue edge of the V4 peak. In the
2D IR spectrum for V1V4 and V1G3V4, cross peaks are observed between the V4 and VI
V1 V1V4 V1+V4-WTEU V4
1600-
1
o01(cm-1) zO(CM-1)
Figure 16. FTIR and 2DIR spectrum for V1, V4, and VIV4 collected at 10 C on
desalted peptides in pH = 1.0 DCl in D20 with 150 mmol of KD 2PO4 . 2DIR spectrum
were collected in ZZYY polarization at T2 = 150 fs.
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isotope peaks (figure 17). These cross-peaks are most easily observed in the lower right corner
of the spectrum as a negative ridge along o3 1544 and 1562 cm'. A cross peak is also
observed in the G3 peptide 2D IR spectrum between the G3 isotope peak and the unlabeled
proline VI peak. This cross peak is most easily observed in the upper left corner of the spectrum
as a positive ridge along (03 ~ 1624 cm-1. Since the G3 and V4 sites are separated from the VI
site by 1 and 2 amino acids respectively, these cross peaks are more likely to result from a
through space as opposed to through bond coupling. Based on the modeling results for the
proline peak in chapter 4 it is likely that these cross peaks are the result of a hydrogen bond
between the G3 and V4 amide N-H moiety's and the VI amide C=0. Simultaneously the G5tG3
2D IR spectrum did not indicate the existence of a longer range coupling across the turn. As a
result it is concluded that the GVGnl forms a closed but lose p-turn with VI to G3 and VI to V4
hydrogen bond contacts. To further explore these findings in the future it would be prudent to
synthesize the 13 CO analogs of the V4 and G3 peptides as well as the 13 CO labeled G3V4
peptide. By using a 13 CO instead of a 13C1 10 label the V4 and G3 site frequencies would be
nearly degenerate with the unlabeled VI site. In the case of the proposed 13CO labeled G3
peptide the frequency splitting between the labeled G3 site and the unlabeled proline site would
be AComax = 3.7 cm-1. As a result this peptide should display a dramatically red shifted isotope
peak akin to what was observed for the TZ2 TT label if the peptide has a G3 to VI hydrogen
bond.
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Figure 17. 2DIR spectrum for G3, V 1V4, and V1 G3V4 collected at 10 *C on desalted peptides in
pH = 1.0 DCl in D20 with 150 mmol of KD 2PO4. 2DIR spectrum were collected in ZZYY
polarization at T2 = 150 fs. Green circles indicate the location of isotope peaks and the
corresponding green lines are provided to indicate the location of cross peaks. In the G3
spectrum the green dots are placed over the peak maximum of the G3 and unlabeled V1 peaks
with omax = 1581.0 and 1614.0 cm 1 respectively. In the V1V4 spectrum the green dots are placed
over the labeled Vi 2/0 and 1/0 peaks with o = 1554.4 and 1572.2 cm 1 along with a dot over the
V4 peak maximum at om, = 1584.1 cm-1. The V1G3V4 peptide has green dots over the VI 2/0
and 1/0 peaks with o = 1554.4 and 1572.2 cm' along with a dot over the V4 and G3 peak
maxima at co. = 1584.1 and 1610.3cm 1 respectively.
5.9 Temperature and Salt Dependence
As discussed earlier in this chapter tropoelastin and long ELPs undergo a phase transition
from a structure that is soluble at low temperature to a 50-60% hydrated coacervate phase above
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the ITT.23,63,67 Never the less the changes to the amide I' spectrum of the small ELPs studied
here are less dramatic (Figure 18).
-V1: pH =1.0, T=10 C
-V1: pH = 1.0, T =60 0C
-- TZ2:pH=2.5,T=5*C
-- TZ2:pH=2.5,T=950 C.
1610 1620 1630 1640 1650 1660 1670 1680 1690O(cm-l)
Figure 18: FTIR spectrum for non-desalted TZ2 in pH = 2.5 DC1 in D20 with no salt
added and non-desalted V1 in pH = 1.0 DCl in D20 with no salt.
Figure 18 is a comparison of FTIR spectrum taken at the end points of the TZ2 and V1 melting
and "folding" transitions respectively. As discussed in chapter 3, at low temperatures the TZ2
peptide displays a large vi contribution that diminishes upon heating as the cross strand beta-
sheet contacts become thermally disordered. In contrast the high temperature spectrum has a
small vi. contribution and is dominated by vii and random coil vibrations. Interestingly the high
temperature TZ2 spectrum is qualitatively similar to the VI spectrum for the putatively
"unfolded," 10 *C, and "folded," 60 *C, states. This comparison demonstrates both that the
GVGn1 peptide exists largely in frayed and disordered conformations at all temperatures and
that the changes in secondary structure for the GVGnl peptide across the "folding" transition are
small.
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Only small changes are observed in the GVGnl amide I' spectrum upon an increase in
temperature and upon addition of salt. In figure 19 temperature dependent FTIR spectra are
presented for WT, VI, G3, and G51G3 in a solution containing DCl in D20 and in a solution
containing DCl and KD2PO4 in D20.
pH = 1.0 DCI in D20
pH = 1.0 DCI in D20 with 150 mmol KD2 PO4
Tempin*C= -10 -15 -20 -25 -30 -35 -40 -45 -50 -55 -60
WT
Vi
G3
G5tG3
1550 1570 1590 1610 1630 1650 1670 1690 1550 1570 1590 1610 1630 1650 1670 1690
(0(cm-1) o(cm-1)
Figure 19. FTIR spectrum for non-desalted WT, V1, G3, and G5tG3 collected as a
function of temperature from 10-60 *C in 5 *C steps. Spectrum in the left column were
prepared in pH = 1.0 DCl in D20 and in the right column in pH = 1.0 DCl in D20 with
150mmol of KD 2PO4 added.
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Here KD 2PO 4 and DCl were added to the solution to create the D4 PO4*, K+, and Cl~ ions in order
to induce protein aggregation.106"'107 From this data we see that no substantial change is observed
for any peptide as a function of temperature regardless of salt concentration. Instead a small blue
shift is observed for the entire amide I' line-shape upon heating. Since this blue shift is small and
continuous with temperature it is attributed to nonspecific thermally induced disordering of the
sample and is not likely to be the result of a structural phase transition. Similarly addition of salt,
at constant temperature, generates a blue shift to the amide I' spectrum (Figure 20). Though in
contrast to the temperature dependent data, the addition of salt to the sample also generates a
subtle change in amide I' line-shape. This change is most pronounced in the region from 1660 to
1690 cm-1 where an increase in intensity is observed as a function of salt addition.
.WT V1% ,
NoSalt 10 C - Salt 10 *C
-- NoSalt 60 TC - Salt 60 *CT
SNoSalt T = 10 C
and No Salt T = 60 *C
- -Salt Ta =10d"C
- - Salt T =60 *C
-G3 G5tG3
displayed with red and blue dashed lines. The FTIIR difference spectrum (No salt - Salt)
at constant temperature is displayed in black.
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In order to quantify the effect of salt addition on turn conformation the VI isotope peak
was fit with 2 Gaussians to determine the degree of conformational change upon heating and salt
addition (Figure 21).
(O(Cm-1) (O(Cm-1) (O(Crf-1)
(cm-1) (O(cm-1) (cm-1)
Figure 21. FTIR spectrum collected on the non-desalted VI peptide. (Left) Temperature
dependent FTIR spectrum collected from T = 10-60 "C in 5 *C steps, (Center) Fit to the
10 *C spectrum, and (Right) Fit to the 60 *C spectrum.
For the VI peptide in pH = 1.0 DC in D20 with no additional salt the VI peak at 10 "C is found
to have a 2/0 and 1/0 peak centered at 1554.0 and 1570.2 cm~1, with populations of 79.4% and
20.6%, and FWHM or 13.7 and 12.5 cm~1 respectively. Upon heating to 60 *C the 2/0 and 1/0
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peaks shift by Ao = +2.0 and +1.2 cm~1, with a population change of AP = +2.3% and -2.3%, and
a AFWHM = +0.6 and 0.0 cm~1 respectively. Similar temperature dependent results are found
for the VI peptide in pH = 1.0 DCl in D20 with 150 mmol KD 2PO4. Upon heating in the
presents of salt the 2/0 and 1/0 peaks blue shift by Ao = +2.0 and -0.2 cm~1, with a population
change of AP = -2.0 % and +2.0 %, and a AFWHM = +0.3 and +2.0 cm~1 respectively. A small
but slightly more substantial change is observed between the salt and no salt data. Upon addition
of salt at 10 *C the 2/0 and 1/0 peaks change by Ao = +2.8 and +1.4 cm1; AFWHM = +3.1 and
+1.8 cm~1; AP = +1.2%, and -1.2% respectively. At 60 *C the 2/0 and 1/0 peaks change by Ao =
2.8 and 0.0 cm1; AFWHM = 2.8 and 3.8 cm-1; AP = -3.1% and +3.1% respectively. The
observation that the addition of salt generates a larger peak shift then an increase in temperature
is also observed for the COOD resonance (Figure 22).
- 10 *C pH=1.0 with no salt
--- 10 *C pH=1.0 with 150 mmol of KD2PO4
- 60 "C pH=1.0 with no salt
--- 60 *C pH=1.0 with 150 mmol of KD2PO4
1710 1720 1730 1740 1750 1760
o(cm-1)
Figure 22. FTIR spectrum collected on the non-desalted VI peptide plotted for the
COOD region.
The COOD resonance is found to blue shift by 2.7 cm-1 upon heating from 10 *C to 60 0C and by
4.0 cm-1 when dissolved in the 150 mmol of KD 2PO4 solution. Though as was the case for the
amide I' resonance these changes are continuous as a function of temperature and salt
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concentration and therefore are not likely to be the result of a structural phase transition. From
these observations it is clear that the VI and COOD peaks blue-shift upon heating or addition of
salt but the underlying 2/0 and 1/0 turn populations are unaffected to within the error of the
measurements performed.
Clearer evidence that increasing the concentration of charged species generates a larger
change to the amide I' spectrum than heating is scene in the VI 2DIR spectrum (Figure 23).
T2 =1.5ps 10C
0.0 mmol
75.0 mmol
150.0 mmol
60 C
,(cm-) 0o1(cm-1 )
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Figure 23. 2DIR spectra of the non-desalted VI peptide as a function of temperature and
salt concentration. All spectra were collected in a ZZZZ polarization geometry with C2 =
1.5ps.
In this figure the V1 T2 = 1.5ps amide I' 2DIR spectrum is given as both a function of salt
concentration and temperature. In contrast to the FTIR spectrum the 2DIR spectrum shows
pronounced changes as a function of salt concentration. As stated earlier upon salt addition the
amide I' line-shape changes in the region from 1660 to 1690 cm. In the 2DIR spectrum this on
diagonal line-shape change occurs in conjunction with the growth of a cross peak between the
1660 to 1690 cm- region and the V1 isotope peak. This cross peak is found to grow
asymmetrically as a function of salt addition with a larger contribution on the blue side centered
at (03 = 1678.0 cm . Since the G3t FTIR difference spectrum shows a pronounced loss feature
centered at 1677.8 cm-1 the cross peak could be the result of the N-terminus interacting with the
VI site lending credence to the proposal from section 5.7.4 that the G3t bends inward towards
the turn. Further experiments and modeling will be required to generate a structure frequency
correlation for the G3 site to confirm the existence of the proposed structure. Never the less the
presence of a cross peak demonstrates the existence of through space coupling and as a result this
data shows that salt addition induces structuring or a hydrophobic collapse.
5.10 Size dependent FTIR
Increasing the size of the peptide is found to increase the red shift of the proline peak.
This observation is illustrated in figures 20 and 21 which show the temperature dependent FTIR
spectra and single value decomposition (SVD) analysis for GVG(VPGVG) 1. 6 and (GVGVP) 251.
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In figure 24 we see that the FTIR spectrum for all peptides contain a similar line-shape with an
increase in the red-shift of the proline resonance as a function of increasing chain
1560 1600 1640 1680 1720
(O(Cmf1)
Figure 24. Temperature dependent FTIR spectra for
where n = 1-6 and the (GVGVP) 251 polymer in pH = 1.0
KD 2PO4.
non-desalted GVG(VPGVG)n
DCl in D20 with 150 mmol of
length at 5.0 *C. This red-shift diminishes upon heating giving a similar proline peak shift for all
peptides at 65 *C. Interestingly the first and second SVD components for all samples retain
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similar peak features that differ only in intensity. As a result our understanding of the spectrum
of the smaller ELPs may provide the requisite insight to assign the spectrum of larger ELPs.
0.270
0.265
0.260
0.255
0.6
0.4
0.2
0.0
-0.2
-0.4
First SVD Component
melting curve
~rn -GVGn1
- GVGn2
- GVGn3
- GVGn4
GVGn5
GVGn6
- (GVGVP)n251
10 20 30 40 50 60 71
Temperature in *C
Second SVD Component
melting curve
10 20 30 40 50 60
Temperature in oC
3
0)(cm-1)
70
(o(cm- 1)
Figure 25. First and Second SVD component spectrum and corresponding melting curves
for GVG(VPGVG). where n = 1-6 and the (GVGVP)251 polymer in pH = 1.0 DCl in D20
with 150 mmol of KD 2PO 4.
In figure 25 we see that (GVGVP) 251 has an abrupt change in its first and second
component SVD melting curves centered at 17 C. In addition in the FTIR data for (GVGVP) 251
in figure 26 shows that the majority of the temperature dependent red shift of the proline peak
occurs over the temperature range 10-20 *C. Since this sample was found to transition from a
low temperature state that does not scatter light to one that scatters light above 17 "C the
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observed temperature dependent changes in the IR spectrum are believed to be the result of the
ITT.
The second component spectrum for GVG(VPGVG)n, where n = 1-6, were found to contain a
local maximum at co - 1612 and 1640 cm-1 and a local minimum at at o ~ 1665 and 1681 cm~1 . The local
maxima represent a blue shift or loss of peak intensity from the proline 2/0 peak and vi antiparallel f-
sheet modes with temperature and the local minima represent a blue shift or gain of peak intensity
for the v|| antiparallel p-sheet mode and an unassigned mode at o) 1681 cm-I with temperature. In
order to characterize the conformational changes that occur for the peptide across the phase
transition the (GVGVP) 251 FTIR spectra were compared to the simulated 2/0, 1/0, and 0/0 FTIR
spectrum of GVGnl from chapter 4.
- 100C GVGVP 251 T = 10 OC
- 15 GVGVP 251 T = 60 OC
-20 GVGnl 0/0
-25 - - - GVGn1 1/0
-30 GVGn1 2/0
-35
-40
-45
- 55
- 60
1600161016201630164016501660167016801690 1600161016201630164016501660167016801690
O(cm-) w(cm-1)
Figure 26. (Left) Temperature dependent FTIR spectrum for (GVGVP) 251 in pH = 1.0
DCl in D20 with 150 mmol of KD2PO4. (Right) A comparison between the GVGVP) 251
FTIR spectrum with the simulated 2/0, 1/0, and 0/0 spectrum for the GVGn1 peptide.
In figure 26 we see that the proline peak in the FTIR spectrum for (GVGVP) 251 at 10 *C,
(proline peak maximum at o = 1608.3 cm'), most closely resembles the simulated GVGnl 2/0
spectrum (proline peak maximum at co = 1616.9 cm). Since the proline resonance acts as a local
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probe of turn structure the red shifted proline peak for the (GVGVP) 251 polymer might have the
same interpretation as in the case of the GVGn1 peptide. If this assumption is correct then the
above temperature dependent FTIR spectrum would suggest a new explanation for elastin's ITT
in which the peptide transitions from a low temperature state containing primarily 2/0 turns
which upon heating diminishes as the population of 1/0 turns increases. Using the equation from
chapter 4 for determining the number of peptide-peptide hydrogen bonds to proline, wAp(cm-1)~ -
13.8-n,, + 1642, gives npp = 2.4. This unlikely prediction may potentially reflect the fact that the red shift
of the proline site in (GVGVP) 2 1 may originate from more than just the formation of the 2/0 turn.
The differences between the structure of GVGn1 and (GVGVP) 251 are not limited to the
relative population of 2/0 and 1/0 turns. In figure 27 is a comparison of the 2D IR ZZYY
spectrum of GVGn1 and (GVGVP) 25 i at T = 10 and 15 C respectively. In addition to the
broader more red shifted proline peak for (GVGVP) 251, we observe the formation of a cross peak
between the vi and vil antiparallel P-sheet modes. This indicates that the polymer, in its unfolded
state, is more structured then the GVGnl peptide under similar conditions. One potential
explanation is that the 1/0 turn in (GVGVP) 251 may contain a population of type II P-turns with
both a V1 to G3 and a G5t to V4 cross strand hydrogen bond generating a unit of p-sheet
structure. In order to assign the mechanism of the ITT in (GVGVP) 2s first this p-sheet structure
has to be identified as well as determining the AG associated with changes in this structure
relative to the AG associated with changes in the turn conformation, main-chain hydration and
side-chain hydration during the ITT.
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GVGn1
174
1
E
11
1580
1580
(GVGVP) 25 1
1620 1660 1700 1580 1620 1660 1700
o01(cm-1) o1 (cm- 1)
Figure 27. ZZYY 2DIR spectrum for the GVGnl (Left column) and (GVGVP) 251 (Right
column) peptides. Desalted GVGnl was collected at T = 10 C and T2 = 150 fs in pH =
1.0 DCl in D20 with 150 mmol of KD2PO4:K 2DPO4 (1:1). (GVGVP) 251 was collected at
T = 15 C and T2 = 150 fs in pH = 1.0 DCl in D20 with 150 mmol of KD2PO4. Dots are
placed to mark the location of the antiparallel P-sheet modes, vi = 1640 and vIl =
1670 cm~1, as well as the location of the GVGnl and (GVGVP) 251 proline peak
maximum at omax = 1614 and 1608.3 cm-1 respectively.
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5.11 Conclusion
The GVGnl peptide on average contains a high population of closed 2/0 and 1/0 turns for
all temperatures and salt concentrations investigated. The VI C=O site is found to be buried in
the interior of the turn forming transient hydrogen bonds with the N-H of the G3 and V4 amide
sites. The hydrogen bonds are scene in the 2D IR spectrum of G3, ViV4, and V1G3V4 as cross
peaks between there corresponding isotope peaks. The transient nature of these cross strand
hydrogen bond contacts are reflected in the G5tG3 spectrum which shows no indication of
coupling between the G5t and G3 amide sites. It was shown that the G5t site is not likely to
contribute a peptide-peptide hydrogen bond to the turn but instead it is partially solvent exposed
owing to its location on the periphery of the peptide turn. This solvent exposure was found to
decrease for the N-terminus as demonstrated by the G3 spectrum which contains a blue shifted
isotope peak. From these results it can be concluded that the GVGn1 contains a closed irregular
turn with the G3 and V4 N-H oriented towards the VI C=O and may potentially contain a highly
mobile N-terminus that is buried in the hydrophobic core of the peptide turn. This turn structure
is durable showing no significant changes with temperature or salt concentration. Based on the
work presented in chapter 4 this stability is most likely the result of steric clashes between the
VI side-chain with the proline pyrrolidine ring. It was shown that the addition of salt generates
the largest changes to the amide I' spectrum and a possible structuring of the N-terminus through
the formation of a p-strand or interaction with the VI site in the turn. It was also found that the
addition of salt generates the most pronounced changes to the amine amide I' band and the off
diagonal cross peak region while not generating a significant shift in isotope peak frequencies.
As a result the driving force for the phase transition for VPGVG sequences is likely due to a
175
hydrophobic effect involving the aggregation of Val side-chains to form a hydrophobic core and
as a result the phase transition does not project significantly onto the amide I' spectrum.
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Figure 1. Electrospray mass spectra in negative ion mode of Fmoc-Ser-OH after one
round of 180 isotope labeling. The molecular weight of neutral unlabeled Fmoc-Ser-OH
is 327.3 amu. Here the Fmoc-Ser-OH natural abundance peak is at 326.1 m/z and the
isotope labeled peaks are at 327.9, 329.1, and 330.1 m/z.
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Figure 3. Analytical HPLC of the unlabeled TZ2 peptide (TZ2-UL) using a C18 HPLC
column with a two-phase buffer gradient: (buffer A) 0.05% TFA in H20 and (buffer B)
80% acetonitrile, 0.043% TFA in H20.
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Figure 4. MALDI of the unlabeled (UL) TZ2 peptide. The molecular weight of neutral
TZ2-UL is 1607.8 amu. Here the main ion, Na* and K' peaks appear at 1607.6, 1629.5,
and 1645.5 m/z respectively.
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Figure 5. Analytical HPLC of 2Z2-S1 using a C18 HPLC column with a two-phase buffer
gradient: (buffer A) 0.05% TFA in H20 and (buffer B) 80% acetonitrile, 0.043% TFA in
H20.
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Figure 6. MALDI of the TZ2-S1 peptide. The molecular weight of neutral TZ2-UL is
1607.8 amu. Here the Na' peaks appear at 1631.9 m/z.
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Figure 7. Analytical HPLC of TZ2-K8 using a C18 HPLC column with a two-phase buffer
gradient: (buffer A) 0.05% TFA in H20 and (buffer B) 80% acetonitrile, 0.043% TFA in
H20.
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Figure 8. MALDI of the TZ2-K8 peptide. The molecular weight of neutral TZ2-UL is
1607.8 amu. Here the Na' peaks appear at 1631.1 m/z.
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Figure 9. Analytical HPLC of TZ2-T10 using a C18 HPLC column with a two-phase buffer
gradient: (buffer A) 0.05% TFA in H20 and (buffer B) 80% acetonitrile, 0.043% TFA in
H20.
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Figure 10. MALDI of the TZ2-T1O peptide. The molecular weight of neutral TZ2-UL is
1607.8 amu. Here the Na* peaks appear at 1633.2 m/z.
193
- J W % 1 0 D M NVI
MC a 0 0 - C0 0 C C) W 4- CON C C
CC
-Dn
CP
C)
Ln
U)
zz
C0
z M
CD
CC
00
00
NJ 7iFigue 1. AnlytcalHPLCof VGGPVG sin a C8 HLC clum wih a wo-has
194
N
H
2
-GVGGPGVG-COOH
599.820
32.215(
>
.8 9
1.800
3 
.788
P
.742
600 
800 
1000 
1200 
1400 
1600 
1800 
m
/z
tcquisition m
ethod n
am
e 
D
IL
shinskyM
edxds\R
PjPpM
a~par
)ate of a
cquition 
2011-08-26T14:l0-07.807-0400
n
strum
ent type 
m
icrolex
kri 
instrum
rent nu
m
ber 
256969.00047
IE delay in [nsl 
160 n
s
kcquistion operation m
ode 
R
eflector
a
m
ple nam
e (file n
am
e prefix) ZI I153_3_\0_EI 
l1\
Laser repetition rate in H
z 
60 H
z
.inear detector voltage 
2.698 kV
teflector detector voltage 
1.618 kV
o
n
 so
u
rce volage 1 
19 kV
bn so
u
rce volage 2 
155 kV
o
n
 so
u
rce lens volage 
95 kV
4um
ber of shots 
200
Ln0)
nics flexAnalysis 
printed: 
8/26/2011 
2:10:28 PM
BRUKER
O
LY
M
ERS\201 1\A
ugust\0826 1\Z 11533__E11\1 
.rm
JiI. 
U
IW
 i
.&
m
a.C
.4 
O
L
.0
'uY-I
Lfn
.
.
 
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
 
.
.
.
.
.
.
.
.
.
.
.
 
.
.
.
.
.
.
 
.
.
.
 
.
.
.
.
 
.
.
pp, Run: R11765_6_7_z1ll53_IESSINGJOSHGVG-vagPGVG
4000.0
3750,0
3500.0
3250,0
3000.0
2750.0
2500.0
2250,0
2000.0
1750.0
1500.0
1250.0-
1000.0
750.0
500,0
250,0
PN:1 
PN:2
0.0-250.0
0.0
@
 8/24/2011 12:12:21 PM
, Method: 4000ulC00K_343Prep Collect by UV Threshold, Iter 3, Inj: 3
PN:6
N
H
2
-GVGAPGVG-COOH
PN
l!M
gPN
:10
L-
25,0
M
inutes
0,y1
41.0
-Aa..
CLL
u
.
CoL
000 s9
z
r
8-v
C)
n
0
!!NJ
WAIN
Figure 14. MA a
of the neutral gi
613.9, 635.8 a I
197
-C ) IM _ g
C C -C n
-U
z
U)
Fraction 1j7eI
Fraction
0
1z
_~0
z
z
1-fl7
Figure 15. Analytical HPLC of GVGVPGVG (Val or GVGn1)
a two-phase buffer gradient: (buffer A) 0.05% TFA
acetonitrile, 0.043% TFA in H20.
using a C18 HPLC column with
in H20 and (buffer B) 80%
198
K)
C
0
b
mv
-C
o C)
U1 C) (A
C) C )
IC
-v
z
Ln
N,
N)Ln
P
N
H
2
-GVGVPGVG-COOH
641.961
574.325
555.196E
3.942
600 
800 
1000 
1200 
1400 
1600
1800
A
cquisition m
ethod n
am
e 
D
-\LeshinkyM
ethods\R
PPepM
ix.par
D
ate of acquisition 
201l-08-26T4:08:3&
745-04:00
Instrum
ent type 
m
icroflex
Scrial in
trm
 n
u
rre
r 
256969.00047
P
E
 delay in [ns] 
160 n
s
A
cquisition operation m
odc 
R
eflector
Sam
ple n
am
e (file n
am
e prefix) ZI I53_1)J9\2
Laser repetition rate in H
z 
60 H
z
Linear 
detector v
oltage 
2.698 kV
R
eflector detector voltage 
1.618 kV
lon so
u
rce v
okage l 
19 kV
lon sou
rce v
oltage 2 
15.5 kV
[on so
u
rce lens voltage 
9.5 kV
N
um
ber 
of shots 
200
00)1
m
/z
printed: 
/26/201 1 
2:08:53 PM
BRUKER 
.
IM
 I=InM
O
LY
M
ERS\2011\A
ugust\08261 1\ZI 1 53_1\_E
9\2
nics nlexanalysis
C-0.-
z
M
E
-v
2j Jn r jt Jkq r VI ' n k" j 0
Wn <D P_ D nF F F 2
CDCo 5
zn
00
C)L
00
00
zj ~
U1 00- H
000
0-200
cow
o & O
-4
Z
0G0
00 I
C)
000
Figure 18. MALDI of the isotope labeled G3t peptidle. The molecular weight of the
neutral unlabeled GVGn1 peptidle is 640.7 amu. Here the main ion, Na* and K* peaks
appear at 644.6, 666.6, and 682.5 m/z respectively.
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Figure 23. Analytical HPLC of G3 using a C18 HPLC column with a two-phase buffer
gradient: (buffer A) 0.05% TFA in H20 and (buffer B) 80% acetonitrile, 0.043% TFA in
H20.
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Figure 24. MALDI of the isotope labeled G3 peptide. The molecular weight of the
neutral unlabeled GVGn1 peptide is 640.7 amu. Here the main ion, Na+ and K+ peaks
appear at 644.6, 666.5, and 682.5 m/z respectively.
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Figure 25. Analytical HPLC of V4 using a C18 HPLC column with a two-phase buffer
gradient: (buffer A) 0.05% TFA in H20 and (buffer B) 80% acetonitrile, 0.043% TFA in
H20.
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Figure 26. MALDI of the isotope labeled V4 peptide. The molecular weight of the
neutral unlabeled GVGn1 peptide is 640.7 amu. Here the main ion, Na* and K' peaks
appear at 644.5, 666.5, and 682.5 m/z respectively.
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Figure 27. Analytical HPLC of G5t G3 using a C18 HPLC column with a two-phase buffer
gradient: (buffer A) 0.05% TFA in H20 and (buffer B) 80% acetonitrile, 0.043% TFA in
H20.
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Figure 28. MALDI of the isotope labeled G~ tG3 peptide. The molecular weight of the
neutral unlabeled GVGn1 peptide is 640.7 amu. Here the main ion, Na' and K+ peaks
appear at 647.6, 669.5, and 685.5 m/z respectively.
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Figure 29. Analytical HPLC of V1V4 using a C18 HPLC column with a two-phase buffer
gradient: (buffer A) 0.05% TFA in H20 and (buffer B) 80% acetonitrile, 0.043% TFA in
H20.
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Figure 31. Analytical HPLC of V1G3V4 using a C18 HPLC column with a two-phase buffer
gradient: (buffer A) 0.05% TFA in H20 and (buffer B) 80% acetonitrile, 0.043% TFA in
H20.
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Figure 32. MALDI of the isotope labeled V1G3V4 peptide. The molecular weight of the
neutral unlabeled GVGn1 peptidle is 640.7 amu. Here the main ion, Na* and K* peaks
appear at 648.6, 670.6, and 686.5 m/z respectively.
215
Figure 33. Analytical HPLC of GVGn2 using a C18 HPLC column with a two-phase buffer
gradient: (buffer A) 0.05% TFA in H20 and (buffer B) 80% acetonitrile, 0.043% TFA in
H20.
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Figure 34. Electrospray mass spectra of the GVGn2 peptide. The molecular weight of
the neutral unlabeled GVGn2 peptide is 1050.2 amu. Here the main ion peaks appear at
1050.9 m/z.
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Figure 35. Analytical HPLC of GVGn3 using a C18 HPLC column with a two-phase buffer
gradient: (buffer A) 0.05% TFA in H20 and (buffer B) 80% acetonitrile, 0.043% TFA in
H20.
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Figure 36. MALDI spectrum of the GVGn3 peptide. The molecular weight of the neutral
unlabeled GVGn3 peptide is 1459.7 amu. Here the Na* peaks appear at 1482.0 m/z.
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Figure 37. Analytical HPLC of GVGn4 using a C18 HPLC column with a two-phase buffer
gradient: (buffer A) 0.05% TFA in H20 and (buffer B) 80% acetonitrile, 0.043% TFA in
H20.
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Figure 38. MALDI spectrum of the GVGn4 peptide. The molecular weight of the neutral
unlabeled GVGn4 peptide is 1869.2 amu. Here the Na* peaks appear at 1891.2 m/z.
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Figure 39. Analytical HPLC of GVGn5 using a C18 HPLC column with a two-phase buffer
gradient: (buffer A) 0.05% TFA in H20 and (buffer B) 80% acetonitrile, 0.043% TFA in
H20.
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Figure 40. MALDI spectrum of the GVGn5 peptide. The molecular weight of the neutral
unlabeled GVGn5 peptide is 2278.7 amu. Here the Na' peaks appear at 2301.8 m/z.
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Figure 41. Analytical HPLC of GVGn6 using a C18 HPLC column with a two-phase buffer
gradient: (buffer A) 0.05% TFA in H20 and (buffer B) 80% acetonitrile, 0.043% TFA in
H20.
224
2709.902
101000-
800-
600-
400-
272.771
200-
0-
1000 1500 2000 2500 3000 3500
Figure 42. MALDI spectrum of the GVGn6 peptide. The molecular weight of the neutral
unlabeled GVGn6 peptide is 2688.2 amu. Here the Na* peaks appear at 2709.9 m/z.
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